This ~~page~~ is ~~part of~~ the ~~FHIR Specification v6.0.0-ballot3: Release 6 Ballot (3rd Draft) (see Ballot Notes ). The current version is 5.0.0 . For a full list~~ Continuous Integration Build of ~~available versions, see~~ FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions icon

4.4.1.521 4.4.1.227 ValueSet http://hl7.org/fhir/ValueSet/report-codes

Responsible Owner: Orders and Observations icon

Work Group

~~Maturity Level : 0~~ ~~Informative~~ Normative

Use Context : Country: World

Official URL : `http://hl7.org/fhir/ValueSet/report-codes`				Version : 6.0.0-ballot3
~~draft~~ active as of ~~2025-04-01~~ 2025-11-27				Computable Name : LOINCDiagnosticReportCodes
Flags :				OID : 2.16.840.1.113883.4.642.3.233

This value set is used in the following places:

Resource: DiagnosticReport.code (CodeableConcept / Preferred )

~~Profile: ExampleLipidProfile: DiagnosticReport.code (CodeableConcept / Preferred )~~

4.4.1.521.1 4.4.1.227.1 Definition

This value set includes LOINC codes that relate to Diagnostic Observations.

4.4.1.521.2 4.4.1.227.2 Content Logical Definition

Generated Narrative: ValueSet report-codes

Last updated: ~~2025-04-01T12:16:37.966+11:00 Profile: Shareable ValueSet~~ 2025-11-27T16:48:47.349Z

Include ~~all~~ codes ~~defined in~~ from http://loinc.org version Not Stated (use latest from terminology server) where STATUS = ACTIVE, ORDER_OBS in Order,Both and CLASSTYPE in 1,2

4.4.1.521.3 4.4.1.227.3 Expansion

This expansion generated ~~01 Apr~~ 27 Nov 2025

ValueSet

Expansion from tx.fhir.org based on Loinc ~~v2.80~~ v2.81

This value set ~~has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown~~ contains 0 concepts

~~Code~~ Display 100000-9 http://loinc.org Health informatics pioneer and the father of LOINC 100001-7 http://loinc.org Health informatics pioneer and cofounder of LOINC 100002-5 http://loinc.org Specimen care is maintained 100003-3 http://loinc.org Team communication is maintained throughout care 100004-1 http://loinc.org Demonstrates knowledge of the expected psychosocial responses to the procedure 100005-8 http://loinc.org Demonstrates knowledge of nutritional management related to the procedure 100006-6 http://loinc.org Demonstrates knowledge of medication management 100007-4 http://loinc.org Demonstrates knowledge of pain management 10000-8 http://loinc.org R wave duration in lead AVR 100008-2 http://loinc.org Demonstrates knowledge of wound management 100009-0 http://loinc.org Demonstrates knowledge of the procedure and expected results 100010-8 http://loinc.org No injury related to procedure equipment, medical supplies, or instrumentation 100011-6 http://loinc.org No injury related to an electrical source 100012-4 http://loinc.org Participates in decisions affecting the patient's plan of care 100013-2 http://loinc.org Participates in the discharge process 100014-0 http://loinc.org Psychosocial health is maintained at or improved from baseline 100015-7 http://loinc.org No injury related to positioning due to care or procedure 10001-6 http://loinc.org R wave duration in lead I 100016-5 http://loinc.org No injury related to a laser source 100017-3 http://loinc.org Perioperative nursing data set outcomes panel [PNDS] 100018-1 http://loinc.org Hospice care Note 100019-9 http://loinc.org ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100020-7 http://loinc.org GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100021-5 http://loinc.org GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100022-3 http://loinc.org IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100023-1 http://loinc.org IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 10002-4 http://loinc.org R wave duration in lead II 100024-9 http://loinc.org SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100025-6 http://loinc.org SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100026-4 http://loinc.org MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100027-2 http://loinc.org SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100028-0 http://loinc.org FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 100029-8 http://loinc.org Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method 100030-6 http://loinc.org Axis I: Temporal aspects score [Mainz Pain Staging System] 100031-4 http://loinc.org Axis II: Spatial aspects score [Mainz Pain Staging System] 10003-2 http://loinc.org R wave duration in lead III 100032-2 http://loinc.org Axis III: Drug taking behavior score [Mainz Pain Staging System] 100033-0 http://loinc.org Axis IV: Utilization of the health care system score [Mainz Pain Staging System] 100034-8 http://loinc.org Provider of automated external defibrillator use 100035-5 http://loinc.org Exam finding location of Chest 100036-3 http://loinc.org Exam finding location of Lung 100037-1 http://loinc.org Patient contact disposition EMS unit 100038-9 http://loinc.org Patient evaluation disposition EMS unit 100039-7 http://loinc.org Crew disposition for patient care EMS unit 10004-0 http://loinc.org R wave duration in lead V1 100040-5 http://loinc.org Patient transport disposition EMS unit 100041-3 http://loinc.org Aminoglycoside [Susceptibility] 100042-1 http://loinc.org Atovaquone [Susceptibility] 100043-9 http://loinc.org Azithromycin+Ethambutol [Susceptibility] 100044-7 http://loinc.org Cefcapene [Susceptibility] 100045-4 http://loinc.org Cefozopran [Susceptibility] 100046-2 http://loinc.org Cefquinome [Susceptibility] 100047-0 http://loinc.org Cefteram [Susceptibility] 100048-8 http://loinc.org Clarithromycin+Ethambutol [Susceptibility] 100049-6 http://loinc.org Eravacycline [Susceptibility] 100050-4 http://loinc.org Erythromycin+Ethambutol [Susceptibility] 100051-2 http://loinc.org Ethambutol+rifAMPin [Susceptibility] 100052-0 http://loinc.org Flomoxef [Susceptibility] 100053-8 http://loinc.org Fluoroquinolone [Susceptibility] 100054-6 http://loinc.org Gamithromycin [Susceptibility] 100055-3 http://loinc.org Optochin [Susceptibility] 100056-1 http://loinc.org Panipenem [Susceptibility] 10005-7 http://loinc.org R wave duration in lead V2 100057-9 http://loinc.org Prothionamide [Susceptibility] 100058-7 http://loinc.org Prulifloxacin [Susceptibility] 100059-5 http://loinc.org Rifapentine [Susceptibility] 100060-3 http://loinc.org Tildipirosin [Susceptibility] 100061-1 http://loinc.org Tosufloxacin [Susceptibility] 100062-9 http://loinc.org Standard Dermatology Outcome Measures panel 100063-7 http://loinc.org Primary skin concern 100064-5 http://loinc.org Itch severity Reporting Period - Reported 10006-5 http://loinc.org R wave duration in lead V3 100065-2 http://loinc.org Satisfied with treatment 100066-0 http://loinc.org Specular microscopy panel 100067-8 http://loinc.org Eye Image magnification 100068-6 http://loinc.org Right eye Fixation point [Angle] 100069-4 http://loinc.org Left eye Fixation point [Angle] 100070-2 http://loinc.org Right cornea Cell density 100071-0 http://loinc.org Left cornea Cell density 100072-8 http://loinc.org Right cornea Coefficient of variation 10007-3 http://loinc.org R wave duration in lead V4 100073-6 http://loinc.org Left cornea Coefficient of variation 100074-4 http://loinc.org Right cornea Hexagonality 100075-1 http://loinc.org Left cornea Hexagonality 100076-9 http://loinc.org Right cornea Endothelial cells counted 100077-7 http://loinc.org Left cornea Endothelial cells counted 100078-5 http://loinc.org Right cornea Endothelial cell area.min 100079-3 http://loinc.org Left cornea Endothelial cell area.min 100080-1 http://loinc.org Right cornea Endothelial cell area.max 10008-1 http://loinc.org R wave duration in lead V5 100081-9 http://loinc.org Left cornea Endothelial cell area.max 100082-7 http://loinc.org Right cornea Endothelial cell area.mean 100083-5 http://loinc.org Left cornea Endothelial cell area.mean 100084-3 http://loinc.org Right cornea Cell area.standard deviation 100085-0 http://loinc.org Left cornea Cell area.standard deviation 100086-8 http://loinc.org Right cornea Type of Analysis method by Specular microscopy 100087-6 http://loinc.org Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot 100088-4 http://loinc.org Taenia solium larva Ab bands panel - Serum by Immunoblot 100089-2 http://loinc.org Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot 1000-9 http://loinc.org DBG Ab [Presence] in Serum or Plasma from Blood product unit 100090-0 http://loinc.org Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot 100091-8 http://loinc.org Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay 100092-6 http://loinc.org Trypanosoma cruzi Ab bands panel - Serum by Immunoblot 100093-4 http://loinc.org Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot 100094-2 http://loinc.org Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot 100095-9 http://loinc.org Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot 100096-7 http://loinc.org Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot 100097-5 http://loinc.org Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot 100098-3 http://loinc.org Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot 10009-9 http://loinc.org R wave duration in lead V6 100099-1 http://loinc.org Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot 100100-7 http://loinc.org Fasciola sp IgG Ab [Presence] in Serum by Immunoassay 100101-5 http://loinc.org Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot 100102-3 http://loinc.org Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot 100103-1 http://loinc.org Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot 100104-9 http://loinc.org Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot 100105-6 http://loinc.org Filaria IgG and IgM panel - Serum 100106-4 http://loinc.org Filaria IgG Ab [Presence] in Serum by Immunoassay 10010-7 http://loinc.org R' wave amplitude in lead AVF 100107-2 http://loinc.org Leishmania sp IgG Ab [Presence] in Serum by Immunoassay 100108-0 http://loinc.org Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay 100109-8 http://loinc.org Leishmania sp Ab bands panel - Serum by Immunoblot 100110-6 http://loinc.org Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot 100111-4 http://loinc.org Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot 100112-2 http://loinc.org Fasciola sp Ab bands panel - Serum by Immunoblot 100113-0 http://loinc.org Helicobacter pylori Ab panel - Serum 100114-8 http://loinc.org Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot 10011-5 http://loinc.org R' wave amplitude in lead AVL 100115-5 http://loinc.org Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot 100116-3 http://loinc.org Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot 100117-1 http://loinc.org Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot 100118-9 http://loinc.org Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot 100119-7 http://loinc.org Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot 100120-5 http://loinc.org Chlamydia trachomatis Ab panel - Serum 100121-3 http://loinc.org Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay 100122-1 http://loinc.org Chlamydophila pneumoniae Ab panel - Serum 10012-3 http://loinc.org R' wave amplitude in lead AVR 100123-9 http://loinc.org Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay 100124-7 http://loinc.org Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay 100125-4 http://loinc.org Chlamydophila psittaci Ab panel - Serum 100126-2 http://loinc.org Bordetella pertussis Ab.IgG panel - Serum 100127-0 http://loinc.org Campylobacter sp Ab panel - Serum 100128-8 http://loinc.org Cryptococcus sp Ag panel - Serum 100129-6 http://loinc.org Schistosoma sp Ab [Titer] in Serum by Hemagglutination 100130-4 http://loinc.org Schistosoma mansoni Ab [Presence] in Serum by Immunoblot 10013-1 http://loinc.org R' wave amplitude in lead I 100131-2 http://loinc.org Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot 100132-0 http://loinc.org Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot 100133-8 http://loinc.org Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot 100134-6 http://loinc.org Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot 100135-3 http://loinc.org Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot 100136-1 http://loinc.org Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot 100137-9 http://loinc.org Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot 100138-7 http://loinc.org Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot 100139-5 http://loinc.org Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot 100140-3 http://loinc.org Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot 100141-1 http://loinc.org Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot 100142-9 http://loinc.org Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot 100143-7 http://loinc.org Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot 100144-5 http://loinc.org Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot 100145-2 http://loinc.org Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot 100146-0 http://loinc.org Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot 100147-8 http://loinc.org Toxoplasma gondii Ab bands panel - Serum by Immunoblot 100148-6 http://loinc.org Schistosoma sp Ab bands panel - Serum by Immunoblot 10014-9 http://loinc.org R' wave amplitude in lead II 100149-4 http://loinc.org 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma 100150-2 http://loinc.org 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma 100151-0 http://loinc.org 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma 100152-8 http://loinc.org 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine 100153-6 http://loinc.org 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine 100154-4 http://loinc.org Specimen collection supervision level 100155-1 http://loinc.org Left cornea Type of Analysis method by Specular microscopy 10015-6 http://loinc.org R' wave amplitude in lead III 100156-9 http://loinc.org SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection 100157-7 http://loinc.org SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing 100158-5 http://loinc.org Microalbumin [Mass/volume] in Urine collected for unspecified duration 100159-3 http://loinc.org Knee Society Score pre-op panel [Knee Society Score] 100160-1 http://loinc.org Knee replacement 100161-9 http://loinc.org Charnley Functional Classification 100162-7 http://loinc.org Knee alignment W standing X-ray measured 100163-5 http://loinc.org Knee medial AndOr lateral instability W full extension 10016-4 http://loinc.org R' wave amplitude in lead V1 100164-3 http://loinc.org Knee AP instability W 90 degree flexion 100165-0 http://loinc.org Knee range of motion 100166-8 http://loinc.org Flexion contracture range of Knee 100167-6 http://loinc.org Extensor lag range of Knee 100168-4 http://loinc.org Knee pain severity with level walking 100169-2 http://loinc.org Knee pain severity with stairs or inclines 1001-7 http://loinc.org DBG Ab [Presence] in Serum or Plasma from Donor 100170-0 http://loinc.org Knee feels normal 100171-8 http://loinc.org Satisfaction with level of knee pain while sitting 10017-2 http://loinc.org R' wave amplitude in lead V2 100172-6 http://loinc.org Satisfaction with level of knee pain while lying in bed 100173-4 http://loinc.org Satisfaction with knee function while getting out of bed 100174-2 http://loinc.org Satisfaction with knee function while performing light household duties 100175-9 http://loinc.org Satisfaction with knee function while performing recreational activities 100176-7 http://loinc.org Expect surgery to relieve pain 100177-5 http://loinc.org Expect surgery will improve ability to perform activities of daily living 100178-3 http://loinc.org Expect surgery will improve ability to perform leisure, recreational, or sports activities 100179-1 http://loinc.org Walk without assistive mobility devices 10018-0 http://loinc.org R' wave amplitude in lead V3 100180-9 http://loinc.org Assistive mobility devices used 100181-7 http://loinc.org Assistive mobility devices used due to health condition 100182-5 http://loinc.org Duration of standing before sitting due to knee discomfort 100183-3 http://loinc.org Duration of walking before stopping due to knee discomfort 100184-1 http://loinc.org How bothersome is knee when walking on an uneven surface 100185-8 http://loinc.org How bothersome is knee when turning or pivoting leg 100186-6 http://loinc.org How bothersome is knee when climbing up or down a flight of stairs 100187-4 http://loinc.org How bothersome is knee when getting up from a low seat without armrests 100188-2 http://loinc.org How bothersome is knee when getting into or out of a car 100189-0 http://loinc.org How bothersome is knee when moving laterally 100190-8 http://loinc.org How bothersome is knee when climbing a ladder or step stool 100191-6 http://loinc.org How bothersome is knee when carrying a bag for one block 100192-4 http://loinc.org How bothersome is knee when squatting 100193-2 http://loinc.org How bothersome is knee when kneeling 100194-0 http://loinc.org How bothersome is knee when running 100195-7 http://loinc.org Pain severity--during activity 100196-5 http://loinc.org Pre-op total score [Knee Society Score] 100197-3 http://loinc.org Exercise activity and pain severity panel 10019-8 http://loinc.org R' wave amplitude in lead V4 100198-1 http://loinc.org Pre-op objective knee indicators score [Knee Society Score] 100199-9 http://loinc.org Pre-op symptoms score [Knee Society Score] 100200-5 http://loinc.org Pre-op patient expectations score [Knee Society Score] 100201-3 http://loinc.org Pre-op functional activities score [Knee Society Score] 100202-1 http://loinc.org Pre-op discretionary knee activities score [Knee Society Score] 100203-9 http://loinc.org Knee Society Score post-op panel [Knee Society Score] 100204-7 http://loinc.org Accuracy of pre-surgery expectations of pain relief 100205-4 http://loinc.org Accuracy of pre-surgery expectations to perform activities of daily living 10020-6 http://loinc.org R' wave amplitude in lead V5 100206-2 http://loinc.org Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities 100207-0 http://loinc.org Post-op total score [Knee Society Score] 100208-8 http://loinc.org Post-op objective knee indicators score [Knee Society Score] 100209-6 http://loinc.org Post-op symptoms score [Knee Society Score] 100210-4 http://loinc.org Post-op patient expectations score [Knee Society Score] 100211-2 http://loinc.org Post-op functional activities score [Knee Society Score] 100212-0 http://loinc.org Post-op discretionary knee activities score [Knee Society Score] 100213-8 http://loinc.org Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method 10021-4 http://loinc.org R' wave amplitude in lead V6 100214-6 http://loinc.org Dental model prior authorization Document 100215-3 http://loinc.org Episode of care medical records Document Transplant surgery 100216-1 http://loinc.org Surgical synoptic report 100217-9 http://loinc.org Synoptic report Narrative Surgical oncology 100218-7 http://loinc.org Surgical oncology of colon cancer synoptic report 100219-5 http://loinc.org Surgical oncology of melanoma cancer synoptic report 100220-3 http://loinc.org Surgical oncology of breast cancer synoptic report 100221-1 http://loinc.org Surgical oncology of thyroid cancer synoptic report 10022-2 http://loinc.org R' wave duration in lead AVF 100222-9 http://loinc.org Surgical oncology of pancreas cancer synoptic report 100223-7 http://loinc.org Physical findings of Retina Narrative 100224-5 http://loinc.org Cardiac left ventricular segmental wall motion by echo panel 100225-2 http://loinc.org Bone density quantitative ultrasound study 100226-0 http://loinc.org Small bowel capsule endoscopy study Document 100227-8 http://loinc.org Colon capsule endoscopy study Document 100228-6 http://loinc.org Upper gastrointestinal capsule endoscopy study Document 100229-4 http://loinc.org Endoscopic ultrasound study Document 10023-0 http://loinc.org R' wave duration in lead AVL 100230-2 http://loinc.org Routine prenatal assessment panel 100231-0 http://loinc.org Endobronchial ultrasound study 100232-8 http://loinc.org Impacts of Events Scale-Revised panel 100233-6 http://loinc.org Reminders brought back feelings about adverse event 100234-4 http://loinc.org Trouble staying asleep 100235-1 http://loinc.org Other things triggered persistent thoughts about adverse event 100236-9 http://loinc.org Felt irritable AndOr angry 100237-7 http://loinc.org Avoided getting upset when unintentionally thought about adverse event 100238-5 http://loinc.org Thought about adverse event unintentionally 100239-3 http://loinc.org Felt as if adverse event did not happen 100240-1 http://loinc.org Avoided reminders of adverse event 100241-9 http://loinc.org Experienced mental images of adverse event 100242-7 http://loinc.org Easily startled 100243-5 http://loinc.org Tried to not think of adverse event 100244-3 http://loinc.org Aware of feelings about adverse event, but did not address them 100245-0 http://loinc.org Feelings about adverse event were numb 100246-8 http://loinc.org Acted or felt the same as during adverse event 100247-6 http://loinc.org Trouble falling asleep 10024-8 http://loinc.org R' wave duration in lead AVR 100248-4 http://loinc.org Waves of strong feelings about adverse event 100249-2 http://loinc.org Tried to remove adverse event from memory 1002-5 http://loinc.org DBG Ab [Presence] in Serum or Plasma 100250-0 http://loinc.org Trouble concentrating 100251-8 http://loinc.org Reminders of adverse event caused physical reactions 100252-6 http://loinc.org Had dreams about adverse event 100253-4 http://loinc.org Felt watchful and on-guard 100254-2 http://loinc.org Tried not to talk about adverse event 10025-5 http://loinc.org R' wave duration in lead I 100255-9 http://loinc.org Total score [Impact of Event Scale-Revised] 100256-7 http://loinc.org Fallen in last 6 months 100257-5 http://loinc.org Feel unsteady when standing or walking 100258-3 http://loinc.org History of fall related injury 100259-1 http://loinc.org Aware of tactile sensations 100260-9 http://loinc.org Easy to describe thoughts AndOr feelings 100261-7 http://loinc.org Critical of own thoughts AndOr feelings 100262-5 http://loinc.org Able to notice distressing thoughts AndOr feelings without having to react 10026-3 http://loinc.org R' wave duration in lead II 100263-3 http://loinc.org Easily distracted 100264-1 http://loinc.org Able to notice thoughts AndOr feelings without being overwhelmed 100265-8 http://loinc.org Aware of dietary intake impact on self 100266-6 http://loinc.org Difficult to describe thoughts AndOr feelings 100267-4 http://loinc.org Aware of auditory stimuli 100268-2 http://loinc.org Able to avoid immediate reaction in difficult situations 100269-0 http://loinc.org Do things without paying attention 100270-8 http://loinc.org Recover quickly from distressing thoughts AndOr images 10027-1 http://loinc.org R' wave duration in lead III 100271-6 http://loinc.org Aware of olfactory stimuli 100272-4 http://loinc.org Aware of visual stimuli 100273-2 http://loinc.org Aware of emotions affect on thoughts AndOr behavior 100274-0 http://loinc.org Observing score [FFMQ] 100275-7 http://loinc.org Describing score [FFMQ] 100276-5 http://loinc.org Acting with awareness score [FFMQ] 100277-3 http://loinc.org Nonjudging score [FFMQ] 100278-1 http://loinc.org Nonreactivity score [FFMQ] 100279-9 http://loinc.org Total score [FFMQ] 100280-7 http://loinc.org Five Facet Mindfulness Questionnaire panel [FFMQ] 100281-5 http://loinc.org D Ab [Units/volume] in Serum or Plasma 100282-3 http://loinc.org Vaccine exemption certificate 100283-1 http://loinc.org Harris Hip Score panel [Harris Hip Score] 100284-9 http://loinc.org Walking - functional ability 100285-6 http://loinc.org Comfortable seated position 100286-4 http://loinc.org Able to board public transportation 100287-2 http://loinc.org Put on shoes and socks 100288-0 http://loinc.org Absence of deformity score [Harris Hip Score] 10028-9 http://loinc.org R' wave duration in lead V1 100289-8 http://loinc.org Absence of hip deformity measurements 100290-6 http://loinc.org Range of motion score [Harris Hip Score] 100291-4 http://loinc.org Total score [Harris Hip Score] 100292-2 http://loinc.org Pre-op patient satisfaction score [Knee Society Score] 100293-0 http://loinc.org Hip Flexion range of motion 100294-8 http://loinc.org Hip Abduction range of motion 100295-5 http://loinc.org Hip Adduction range of motion 100296-3 http://loinc.org Hip External rotation range of motion 10029-7 http://loinc.org R' wave duration in lead V2 100297-1 http://loinc.org Hip Internal rotation range of motion 100298-9 http://loinc.org Repetition count 100299-7 http://loinc.org Post-op patient satisfaction score [Knee Society Score] 100300-3 http://loinc.org End time Unspecified body region 100301-1 http://loinc.org Start time Unspecified body region 100302-9 http://loinc.org Time period start and end panel Unspecified body region 100303-7 http://loinc.org Condition certainty of presence 100304-5 http://loinc.org Flights climbed [#] Reporting Period 10030-5 http://loinc.org R' wave duration in lead V3 100305-2 http://loinc.org IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method 100306-0 http://loinc.org IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method 100307-8 http://loinc.org Behavioral screening elder mistreatment 100308-6 http://loinc.org Need help getting to essential places 100309-4 http://loinc.org Activity support person 100310-2 http://loinc.org Reliability of support person 100311-0 http://loinc.org Need help to make sure there is enough food, medicines or any other things needed in house 100312-8 http://loinc.org Person or persons that makes sure there is enough food, medicines or any other things needed in house 10031-3 http://loinc.org R' wave duration in lead V4 100313-6 http://loinc.org Need help with household things such as cook meals, help feed, or provide correct medicines each day 100314-4 http://loinc.org Need help with house cleaning or yard work 100315-1 http://loinc.org Need help getting out of bed, showered, or dressed 100316-9 http://loinc.org Need help to make sure bills get paid 100317-7 http://loinc.org Relationship of usual support person for daily activities 100318-5 http://loinc.org Have help with finances AndOr financial decisions 100319-3 http://loinc.org Relationship of financial support person 100320-1 http://loinc.org Financial support person usually asks for permission before making decisions 10032-1 http://loinc.org R' wave duration in lead V5 100321-9 http://loinc.org Financial support person usually makes good decisions about finances 100322-7 http://loinc.org Have access to paperwork for financial decisions made 100323-5 http://loinc.org Financial support person forged signature 100324-3 http://loinc.org Coercion of financial support person for signing a document in order to get money or possessions 100325-0 http://loinc.org Experienced theft by support person 100326-8 http://loinc.org Money spent or property sold without permission 100327-6 http://loinc.org Stranger forged signature for financial gain 100328-4 http://loinc.org Stranger forced document signature for financial gain 100329-2 http://loinc.org Feared for safety due to verbal attack 1003-3 http://loinc.org Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma 100330-0 http://loinc.org Felt humiliated due to ridicule 100331-8 http://loinc.org Coerced to do something 100332-6 http://loinc.org Ignored by close friend or relative for extended period 100333-4 http://loinc.org Physically hit or threatened 100334-2 http://loinc.org Been physically hurt with some degree of injury 100335-9 http://loinc.org Coerced sexual activity 100336-7 http://loinc.org Coerced touching of private body parts of self or others 100337-5 http://loinc.org Coerced to undress or expose private body area 100338-3 http://loinc.org Photographed in any degree of nudity without consent 10033-9 http://loinc.org R' wave duration in lead V6 100339-1 http://loinc.org Experienced attempted physical restraint 100340-9 http://loinc.org Range of motion panel Hip 100341-7 http://loinc.org Rubella virus IgG Ab index [Units/volume] in Serum and CSF 100342-5 http://loinc.org Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry 100343-3 http://loinc.org Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection 100344-1 http://loinc.org Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection 100345-8 http://loinc.org Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection 100346-6 http://loinc.org Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG 10034-7 http://loinc.org S wave amplitude in lead AVF 100347-4 http://loinc.org Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG 100348-2 http://loinc.org Model for end-stage liver disease sodium score 100349-0 http://loinc.org US.doppler Penis vessels W vasodilator IV 100350-8 http://loinc.org Sesamum indicum 1 IgE Ab [Units/volume] in Serum 100351-6 http://loinc.org Pioglitazone [Presence] in Serum or Plasma 100352-4 http://loinc.org Rosiglitazone [Presence] in Serum or Plasma 100353-2 http://loinc.org Norwalk Community Health Center Screening Tool [NCHC] 10035-4 http://loinc.org S wave amplitude in lead AVL 100354-0 http://loinc.org Frequency of participating in multi-modal communication without assistance 100355-7 http://loinc.org Frequency of participating in spoken language expression communication without assistance 100356-5 http://loinc.org Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection 100357-3 http://loinc.org Naloxone [Presence] in Cord tissue by Screen method 100358-1 http://loinc.org Phentermine [Presence] in Cord tissue by Screen method 100359-9 http://loinc.org Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay 100360-7 http://loinc.org Brief Resilience Scale panel [BRS] 100361-5 http://loinc.org Quickly recover from bad events 10036-2 http://loinc.org S wave amplitude in lead AVR 100362-3 http://loinc.org Difficulty making it through stressful events 100363-1 http://loinc.org Easily recover from a stressful event 100364-9 http://loinc.org Difficulty recovering from bad events 100365-6 http://loinc.org Easily recover from difficulties 100366-4 http://loinc.org Lengthy recovery from setbacks 100367-2 http://loinc.org Total Score BRS 100368-0 http://loinc.org Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS 100369-8 http://loinc.org NM Thyroid gland Views W Tl-201 IV 10037-0 http://loinc.org S wave amplitude in lead I 100370-6 http://loinc.org Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection 100371-4 http://loinc.org Titin Ab [Units/volume] in Serum by Immunoassay 100372-2 http://loinc.org Abiraterone [Mass/volume] in Serum or Plasma 100373-0 http://loinc.org Eucheuma IgG Ab [Units/volume] in Serum 100374-8 http://loinc.org Aloe vera IgG Ab [Units/volume] in Serum 100375-5 http://loinc.org Anise IgG Ab [Units/volume] in Serum 100376-3 http://loinc.org Bambusa vulgaris IgG Ab [Units/volume] in Serum 100377-1 http://loinc.org Goat cheese IgG Ab [Units/volume] in Serum 100378-9 http://loinc.org Sheep cheese IgG Ab [Units/volume] in Serum 100379-7 http://loinc.org Leeks IgG Ab [Units/volume] in Serum 100380-5 http://loinc.org Red cabbage IgG Ab [Units/volume] in Serum 100381-3 http://loinc.org Mentha balsamea Wild IgG Ab [Units/volume] in Serum 100382-1 http://loinc.org FDA package insert REMS addressed risk 100383-9 http://loinc.org Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection 100384-7 http://loinc.org Rapeseed IgG Ab [Units/volume] in Serum 100385-4 http://loinc.org Corn salad IgG Ab [Units/volume] in Serum 100386-2 http://loinc.org Rosemary IgG Ab [Units/volume] in Serum 100387-0 http://loinc.org Poppy Seed IgG Ab [Units/volume] in Serum 10038-8 http://loinc.org S wave amplitude in lead II 100388-8 http://loinc.org Cocoa IgG Ab [Units/volume] in Serum 100389-6 http://loinc.org Pistachio IgG Ab [Units/volume] in Serum 100390-4 http://loinc.org Sunflower Seed IgG Ab [Units/volume] in Serum 100391-2 http://loinc.org Dates IgG Ab [Units/volume] in Serum 100392-0 http://loinc.org Duck meat IgG Ab [Units/volume] in Serum 100393-8 http://loinc.org Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum 100394-6 http://loinc.org Astacoidea IgG Ab [Units/volume] in Serum 100395-3 http://loinc.org Carob IgG Ab [Units/volume] in Serum 10039-6 http://loinc.org S wave amplitude in lead III 100396-1 http://loinc.org Brassica napus IgG Ab [Units/volume] in Serum 100397-9 http://loinc.org Goat Meat IgG Ab [Units/volume] in Serum 100398-7 http://loinc.org Goose meat IgG Ab [Units/volume] in Serum 100399-5 http://loinc.org Ostrich meat IgG Ab [Units/volume] in Serum 100400-1 http://loinc.org Quail meat IgG Ab [Units/volume] in Serum 100401-9 http://loinc.org Rabbit meat IgG Ab [Units/volume] in Serum 100402-7 http://loinc.org Venison meat IgG Ab [Units/volume] in Serum 100403-5 http://loinc.org Guineafowl IgG Ab [Units/volume] in Serum 10040-4 http://loinc.org S wave amplitude in lead V1 100404-3 http://loinc.org Horse meat IgG Ab [Units/volume] in Serum 100405-0 http://loinc.org Kefir IgG Ab [Units/volume] in Serum 100406-8 http://loinc.org Butter IgG Ab [Units/volume] in Serum 100407-6 http://loinc.org Camembert cheese IgG Ab [Units/volume] in Serum 100408-4 http://loinc.org Emmental cheese IgG Ab [Units/volume] in Serum 100409-2 http://loinc.org Processed cheese IgG Ab [Units/volume] in Serum 1004-1 http://loinc.org Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells 100410-0 http://loinc.org Curd cheese IgG Ab [Units/volume] in Serum 100411-8 http://loinc.org Sugar Beet IgG Ab [Units/volume] in Serum 10041-2 http://loinc.org S wave amplitude in lead V2 100412-6 http://loinc.org Chinese cabbage IgG Ab [Units/volume] in Serum 100413-4 http://loinc.org Fennel Fresh IgG Ab [Units/volume] in Serum 100414-2 http://loinc.org Gourd IgG Ab [Units/volume] in Serum 100415-9 http://loinc.org Kale IgG Ab [Units/volume] in Serum 100416-7 http://loinc.org Savoy cabbage IgG Ab [Units/volume] in Serum 100417-5 http://loinc.org Vitis sp leaf IgG Ab [Units/volume] in Serum 100418-3 http://loinc.org Liquorice IgG Ab [Units/volume] in Serum 100419-1 http://loinc.org Snow pea IgG Ab [Units/volume] in Serum 10042-0 http://loinc.org S wave amplitude in lead V3 100420-9 http://loinc.org Fava bean IgG Ab [Units/volume] in Serum 100421-7 http://loinc.org Chick Pea IgG Ab [Units/volume] in Serum 100422-5 http://loinc.org Chicory IgG Ab [Units/volume] in Serum 100423-3 http://loinc.org Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum 100424-1 http://loinc.org 8(9)-Cholestenol [Mass/volume] in Serum or Plasma 100425-8 http://loinc.org DiHydro T-Mas [Mass/volume] in Serum or Plasma 100426-6 http://loinc.org Squalene [Mass/volume] in Serum or Plasma 100427-4 http://loinc.org Stigmasterol [Mass/volume] in Serum or Plasma 100428-2 http://loinc.org Carnitine free and total and acylcarnitine panel - Urine 100429-0 http://loinc.org LRBA deficiency panel - Blood 100430-8 http://loinc.org Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) 100431-6 http://loinc.org Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) 100432-4 http://loinc.org Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) 100433-2 http://loinc.org Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) 100434-0 http://loinc.org Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection 100435-7 http://loinc.org Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay 100436-5 http://loinc.org Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay 100437-3 http://loinc.org Norsufentanil [Mass/volume] in Urine by Confirmatory method 10043-8 http://loinc.org S wave amplitude in lead V4 100438-1 http://loinc.org Adolescent medicine Outpatient Progress note 100439-9 http://loinc.org Allergy and Immunology Outpatient Progress note 100440-7 http://loinc.org Allergy Outpatient Progress note 100441-5 http://loinc.org Attending Outpatient Progress note 100442-3 http://loinc.org Audiology Outpatient Progress note 100443-1 http://loinc.org Bariatric surgery Outpatient Progress note 100444-9 http://loinc.org Blood banking and transfusion medicine Outpatient Progress note 100445-6 http://loinc.org Bone Marrow Transplant Outpatient Progress note 10044-6 http://loinc.org S wave amplitude in lead V5 100446-4 http://loinc.org Breastfeeding Outpatient Progress note 100447-2 http://loinc.org Burn management Outpatient Progress note 100448-0 http://loinc.org Cardiac surgery Outpatient Progress note 100449-8 http://loinc.org Cardiopulmonary Outpatient Progress note 100450-6 http://loinc.org Child and adolescent psychiatry Outpatient Progress note 100451-4 http://loinc.org Chiropractic medicine Outpatient Progress note 100452-2 http://loinc.org Clinical cardiac electrophysiology Outpatient Progress note 10045-3 http://loinc.org S wave amplitude in lead V6 100453-0 http://loinc.org Clinical genetics Outpatient Progress note 100454-8 http://loinc.org Clinical neurophysiology Outpatient Progress note 100455-5 http://loinc.org Clinical pathology Outpatient Progress note 100456-3 http://loinc.org Colon and rectal surgery Outpatient Progress note 100457-1 http://loinc.org Consultant Outpatient Progress note 100458-9 http://loinc.org Outpatient COVID-19 Intubation Progress note 100459-7 http://loinc.org Outpatient COVID-19 Progress note 100460-5 http://loinc.org Dermatology Outpatient Progress note 10046-1 http://loinc.org S wave duration in lead AVF 100461-3 http://loinc.org Developmental-behavioral pediatrics Outpatient Progress note 100462-1 http://loinc.org Dialysis and Therapeutic apheresis Outpatient Progress note 100463-9 http://loinc.org Eating disorders Outpatient Progress note 100464-7 http://loinc.org Endocrinology Outpatient Progress note 100465-4 http://loinc.org Family medicine Outpatient Progress note 100466-2 http://loinc.org Gastroenterology Outpatient Progress note 100467-0 http://loinc.org Geriatric medicine Outpatient Progress note 100468-8 http://loinc.org Gynecologic oncology Outpatient Progress note 100469-6 http://loinc.org Gynecology Outpatient Progress note 100470-4 http://loinc.org Healthcare navigator Outpatient Progress note 100471-2 http://loinc.org Heart failure Outpatient Progress note 100472-0 http://loinc.org Heart failure+Transplant cardiology Outpatient Progress note 100473-8 http://loinc.org Hematology Outpatient Progress note 100474-6 http://loinc.org Hematology+Medical oncology Outpatient Progress note 100475-3 http://loinc.org Hepatology Outpatient Progress note 100476-1 http://loinc.org Immunology Outpatient Progress note 100477-9 http://loinc.org Infectious disease Outpatient Progress note 100478-7 http://loinc.org Internal medicine Outpatient Progress note 10047-9 http://loinc.org S wave duration in lead AVL 100479-5 http://loinc.org Interventional cardiology Outpatient Progress note 100480-3 http://loinc.org Interventional radiology Outpatient Progress note 100481-1 http://loinc.org Outpatient Mechanical circulatory support Progress note 100482-9 http://loinc.org Medical Aid in Dying Outpatient Progress note 100483-7 http://loinc.org Mental health Outpatient Progress note 100484-5 http://loinc.org Multi-specialty program Outpatient Progress note 100485-2 http://loinc.org Neonatal perinatal medicine Outpatient Progress note 100486-0 http://loinc.org Nephrology Outpatient Progress note 10048-7 http://loinc.org S wave duration in lead AVR 100487-8 http://loinc.org Neurological surgery Outpatient Progress note 100488-6 http://loinc.org Neurology Outpatient Progress note 100489-4 http://loinc.org Neurology with special qualifications in child neurology Outpatient Progress note 100490-2 http://loinc.org Nurse practitioner Outpatient Progress note 100491-0 http://loinc.org Nurse Outpatient Progress note 100492-8 http://loinc.org Nutrition and dietetics Outpatient Progress note 100493-6 http://loinc.org Obstetrics and Gynecology Outpatient Progress note 100494-4 http://loinc.org Obstetrics Outpatient Progress note 10049-5 http://loinc.org S wave duration in lead I 100495-1 http://loinc.org Occupational therapy Outpatient Progress note 100496-9 http://loinc.org Oncology Outpatient Progress note 100497-7 http://loinc.org Ophthalmology Outpatient Progress note 100498-5 http://loinc.org Optometry Outpatient Progress note 100499-3 http://loinc.org Oral and Maxillofacial Surgery Outpatient Progress note 100500-8 http://loinc.org Orthopaedic surgery Outpatient Progress note 100501-6 http://loinc.org Orthotics prosthetics Outpatient Progress note 100502-4 http://loinc.org Otolaryngology Outpatient Progress note 10050-3 http://loinc.org S wave duration in lead II 100503-2 http://loinc.org Pain medicine Outpatient Progress note 100504-0 http://loinc.org Palliative care Outpatient Progress note 100505-7 http://loinc.org Pediatric cardiology Outpatient Progress note 100506-5 http://loinc.org Pediatric dermatology Outpatient Progress note 100507-3 http://loinc.org Pediatric endocrinology Outpatient Progress note 100508-1 http://loinc.org Pediatric gastroenterology Outpatient Progress note 100509-9 http://loinc.org Pediatric hematology-oncology Outpatient Progress note 100510-7 http://loinc.org Pediatric infectious diseases Outpatient Progress note 10051-1 http://loinc.org S wave duration in lead III 100511-5 http://loinc.org Pediatric otolaryngology Outpatient Progress note 100512-3 http://loinc.org Pediatric pulmonology Outpatient Progress note 100513-1 http://loinc.org Pediatric rheumatology Outpatient Progress note 100514-9 http://loinc.org Pediatric surgery Outpatient Progress note 100515-6 http://loinc.org Pediatric transplant hepatology Outpatient Progress note 100516-4 http://loinc.org Pediatric urology Outpatient Progress note 100517-2 http://loinc.org Pharmacogenomics Outpatient Progress note 100518-0 http://loinc.org Physical medicine and rehab Outpatient Progress note 100519-8 http://loinc.org Physical therapy Outpatient Progress note 100520-6 http://loinc.org Plastic surgery Outpatient Progress note 100521-4 http://loinc.org Podiatry Outpatient Progress note 100522-2 http://loinc.org Psychiatry Hospital Progress note 100523-0 http://loinc.org Psychology Outpatient Progress note 100524-8 http://loinc.org Pulmonary Outpatient Progress note 100525-5 http://loinc.org Radiation oncology Outpatient Progress note 100526-3 http://loinc.org Radiology Outpatient Progress note 100527-1 http://loinc.org Recreational therapy Outpatient Progress note 100528-9 http://loinc.org Reproductive endocrinology and infertility Outpatient Progress note 10052-9 http://loinc.org S wave duration in lead V1 100529-7 http://loinc.org Research Outpatient Progress note 100530-5 http://loinc.org Rheumatology Outpatient Progress note 100531-3 http://loinc.org Sleep medicine Outpatient Progress note 100532-1 http://loinc.org Social worker Outpatient Progress note 100533-9 http://loinc.org Solid Organ Transplant Outpatient Progress note 100534-7 http://loinc.org Speech-language pathology Outpatient Progress note 100535-4 http://loinc.org Spinal surgery Outpatient Progress note 100536-2 http://loinc.org Sports medicine Outpatient Progress note 10053-7 http://loinc.org S wave duration in lead V2 100537-0 http://loinc.org Surgery of the hand Outpatient Progress note 100538-8 http://loinc.org Telehealth+Outpatient Progress note 100539-6 http://loinc.org Thromboembolism Outpatient Progress note 100540-4 http://loinc.org Transplant surgery Outpatient Progress note 100541-2 http://loinc.org Trauma Outpatient Progress note 100542-0 http://loinc.org Urology Outpatient Progress note 100543-8 http://loinc.org Vascular neurology Outpatient Progress note 100544-6 http://loinc.org Vascular surgery Outpatient Progress note 10054-5 http://loinc.org S wave duration in lead V3 100545-3 http://loinc.org Wound care management Outpatient Progress note 100546-1 http://loinc.org Wound, Ostomy, and Continence Care Outpatient Progress note 100547-9 http://loinc.org Adolescent medicine Hospital Progress note 100548-7 http://loinc.org Allergy and Immunology Hospital Progress note 100549-5 http://loinc.org Allergy Hospital Progress note 100550-3 http://loinc.org Attending Hospital Progress note 100551-1 http://loinc.org Audiology Hospital Progress note 10055-2 http://loinc.org S wave duration in lead V4 100552-9 http://loinc.org Bariatric surgery Hospital Progress note 100553-7 http://loinc.org Blood banking and transfusion medicine Hospital Progress note 100554-5 http://loinc.org Bone Marrow Transplant Hospital Progress note 100555-2 http://loinc.org Breastfeeding Hospital Progress note 100556-0 http://loinc.org Burn management Hospital Progress note 100557-8 http://loinc.org Cardiac surgery Hospital Progress note 100558-6 http://loinc.org Cardiopulmonary Hospital Progress note 100559-4 http://loinc.org Child and adolescent psychiatry Hospital Progress note 10056-0 http://loinc.org S wave duration in lead V5 100560-2 http://loinc.org Clinical cardiac electrophysiology Hospital Progress note 100561-0 http://loinc.org Clinical genetics Hospital Progress note 100562-8 http://loinc.org Clinical neurophysiology Hospital Progress note 100563-6 http://loinc.org Clinical pathology Hospital Progress note 100564-4 http://loinc.org Colon and rectal surgery Hospital Progress note 100565-1 http://loinc.org Consultant Hospital Progress note 100566-9 http://loinc.org Dentistry Hospital Progress note 100567-7 http://loinc.org Dermatology Hospital Progress note 100568-5 http://loinc.org Developmental-behavioral pediatrics Hospital Progress note 100569-3 http://loinc.org Dialysis and Therapeutic apheresis Hospital Progress note 100570-1 http://loinc.org Eating disorders Hospital Progress note 100571-9 http://loinc.org Endocrinology Hospital Progress note 100572-7 http://loinc.org Family medicine Hospital Progress note 100573-5 http://loinc.org Gastroenterology Hospital Progress note 100574-3 http://loinc.org General medicine Hospital Progress note 100575-0 http://loinc.org Geriatric medicine Hospital Progress note 100576-8 http://loinc.org Gynecologic oncology Hospital Progress note 100577-6 http://loinc.org Gynecology Hospital Progress note 10057-8 http://loinc.org S wave duration in lead V6 100578-4 http://loinc.org Healthcare navigator Hospital Progress note 100579-2 http://loinc.org Heart failure Hospital Progress note 1005-8 http://loinc.org Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma 100580-0 http://loinc.org Heart failure+Transplant cardiology Hospital Progress note 100581-8 http://loinc.org Hematology Hospital Progress note 100582-6 http://loinc.org Hematology+Medical oncology Hospital Progress note 100583-4 http://loinc.org Hepatology Hospital Progress note 100584-2 http://loinc.org Immunology Hospital Progress note 100585-9 http://loinc.org Infectious disease Hospital Progress note 10058-6 http://loinc.org S' wave amplitude in lead AVF 100586-7 http://loinc.org Internal medicine Hospital Progress note 100587-5 http://loinc.org Interventional cardiology Hospital Progress note 100588-3 http://loinc.org Interventional radiology Hospital Progress note 100589-1 http://loinc.org Hospital Mechanical circulatory support Progress note 100590-9 http://loinc.org Medical Aid in Dying Hospital Progress note 100591-7 http://loinc.org Mental health Hospital Progress note 100592-5 http://loinc.org Multi-specialty program Hospital Progress note 100593-3 http://loinc.org Neonatal perinatal medicine Hospital Progress note 10059-4 http://loinc.org S' wave amplitude in lead AVL 100594-1 http://loinc.org Nephrology Hospital Progress note 100595-8 http://loinc.org Neurological surgery Hospital Progress note 100596-6 http://loinc.org Neurology Hospital Progress note 100597-4 http://loinc.org Neurology with special qualifications in child neurology Hospital Progress note 100598-2 http://loinc.org Nurse practitioner Hospital Progress note 100599-0 http://loinc.org Nurse Hospital Progress note 100600-6 http://loinc.org Nutrition and dietetics Hospital Progress note 100601-4 http://loinc.org Obstetrics and Gynecology Hospital Progress note 10060-2 http://loinc.org S' wave amplitude in lead AVR 100602-2 http://loinc.org Obstetrics Hospital Progress note 100603-0 http://loinc.org Occupational therapy Hospital Progress note 100604-8 http://loinc.org Oncology Hospital Progress note 100605-5 http://loinc.org Ophthalmology Hospital Progress note 100606-3 http://loinc.org Oral and Maxillofacial Surgery Hospital Progress note 100607-1 http://loinc.org Orthopaedic surgery Hospital Progress note 100608-9 http://loinc.org Orthotics prosthetics Hospital Progress note 100609-7 http://loinc.org Otolaryngology Hospital Progress note 10061-0 http://loinc.org S' wave amplitude in lead I 100610-5 http://loinc.org Pain medicine Hospital Progress note 100611-3 http://loinc.org Palliative care Hospital Progress note 100612-1 http://loinc.org Pastoral care Hospital Progress note 100613-9 http://loinc.org Pediatric cardiology Hospital Progress note 100614-7 http://loinc.org Pediatric dermatology Hospital Progress note 100615-4 http://loinc.org Pediatric endocrinology Hospital Progress note 100616-2 http://loinc.org Pediatric gastroenterology Hospital Progress note 100617-0 http://loinc.org Pediatric hematology-oncology Hospital Progress note 100618-8 http://loinc.org Pediatric infectious diseases Hospital Progress note 100619-6 http://loinc.org Pediatric otolaryngology Hospital Progress note 100620-4 http://loinc.org Pediatric pulmonology Hospital Progress note 100621-2 http://loinc.org Pediatric rheumatology Hospital Progress note 100622-0 http://loinc.org Pediatric surgery Hospital Progress note 100623-8 http://loinc.org Pediatric transplant hepatology Hospital Progress note 100624-6 http://loinc.org Pharmacogenomics Hospital Progress note 100625-3 http://loinc.org Pharmacology Hospital Progress note 100626-1 http://loinc.org Physical medicine and rehab Hospital Progress note 100627-9 http://loinc.org Physical therapy Hospital Progress note 10062-8 http://loinc.org S' wave amplitude in lead II 100628-7 http://loinc.org Plastic surgery Hospital Progress note 100629-5 http://loinc.org Podiatry Hospital Progress note 100630-3 http://loinc.org Psychology Hospital Progress note 100631-1 http://loinc.org Radiation oncology Hospital Progress note 100632-9 http://loinc.org Radiology Hospital Progress note 100633-7 http://loinc.org Rapid response team Hospital Progress note 100634-5 http://loinc.org Recreational therapy Hospital Progress note 100635-2 http://loinc.org Reproductive endocrinology and infertility Hospital Progress note 10063-6 http://loinc.org S' wave amplitude in lead III 100636-0 http://loinc.org Research Hospital Progress note 100637-8 http://loinc.org Rheumatology Hospital Progress note 100638-6 http://loinc.org Sleep medicine Hospital Progress note 100639-4 http://loinc.org Social worker Hospital Progress note 100640-2 http://loinc.org Solid Organ Transplant Hospital Progress note 100641-0 http://loinc.org Speech-language pathology Hospital Progress note 100642-8 http://loinc.org Spinal surgery Hospital Progress note 100643-6 http://loinc.org Surgery of the hand Hospital Progress note 10064-4 http://loinc.org S' wave amplitude in lead V1 100644-4 http://loinc.org Thromboembolism Hospital Progress note 100645-1 http://loinc.org Trauma Hospital Progress note 100646-9 http://loinc.org Urology Hospital Progress note 100647-7 http://loinc.org Vascular neurology Hospital Progress note 100648-5 http://loinc.org Vascular surgery Hospital Progress note 100649-3 http://loinc.org Wound care management Hospital Progress note 100650-1 http://loinc.org Wound, Ostomy, and Continence Care Hospital Progress note 10065-1 http://loinc.org S' wave amplitude in lead V2 100651-9 http://loinc.org Hospital COVID-19 Intubation Progress note 100652-7 http://loinc.org Pure tone bone conduction threshold audiometry panel 100653-5 http://loinc.org Pure tone air conduction threshold audiometry panel 100654-3 http://loinc.org Pyruvate kinase M2 [Presence] in Stool 100655-0 http://loinc.org XR Sella turcica Lateral 100656-8 http://loinc.org Maternal and fetal medicine Outpatient Progress note 100657-6 http://loinc.org Maternal and fetal medicine Telephone encounter+Hospital Progress note 100658-4 http://loinc.org Hospital COVID-19 Progress note 100659-2 http://loinc.org Maternal and fetal medicine Hospital Progress note 1006-6 http://loinc.org Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells 100660-0 http://loinc.org Maternal and fetal medicine Telephone encounter+Outpatient Progress note 100661-8 http://loinc.org Psychiatry Outpatient Progress note 100662-6 http://loinc.org Cortisol free and total panel - Serum or Plasma 100663-4 http://loinc.org TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method 100664-2 http://loinc.org NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method 100665-9 http://loinc.org NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method 100666-7 http://loinc.org NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method 100667-5 http://loinc.org NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method 100668-3 http://loinc.org NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method 10066-9 http://loinc.org S' wave amplitude in lead V3 100669-1 http://loinc.org NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method 100670-9 http://loinc.org RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus 100671-7 http://loinc.org Aspergillus sp DNA [Presence] in Blood by NAA with probe detection 100672-5 http://loinc.org Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection 100673-3 http://loinc.org Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection 100674-1 http://loinc.org BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 100675-8 http://loinc.org Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection 100676-6 http://loinc.org Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection 10067-7 http://loinc.org S' wave amplitude in lead V4 100677-4 http://loinc.org Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection 100678-2 http://loinc.org Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 100679-0 http://loinc.org Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection 100680-8 http://loinc.org Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 100681-6 http://loinc.org Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection 100682-4 http://loinc.org Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 100683-2 http://loinc.org Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection 100684-0 http://loinc.org Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 10068-5 http://loinc.org S' wave amplitude in lead V5 100685-7 http://loinc.org JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection 100686-5 http://loinc.org JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection 100687-3 http://loinc.org JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection 100688-1 http://loinc.org Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 100689-9 http://loinc.org Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection 100690-7 http://loinc.org Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection 100691-5 http://loinc.org Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection 100692-3 http://loinc.org Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection 10069-3 http://loinc.org S' wave amplitude in lead V6 100693-1 http://loinc.org Pneumocystis jirovecii DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection 100694-9 http://loinc.org SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method 100695-6 http://loinc.org Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative 100696-4 http://loinc.org CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal 100697-2 http://loinc.org Interventional radiology Outpatient Note 100698-0 http://loinc.org Social Determinants of Health screening report Document 100699-8 http://loinc.org Rifabutin+Ethambutol [Susceptibility] 100700-4 http://loinc.org Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection 10070-1 http://loinc.org S' wave duration in lead AVF 100701-2 http://loinc.org Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection 100702-0 http://loinc.org Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection 100703-8 http://loinc.org Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection 100704-6 http://loinc.org Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection 100705-3 http://loinc.org Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection 100706-1 http://loinc.org Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection 100707-9 http://loinc.org Granulocytes [#/volume] in Peritoneal dialysis fluid by Automated count 100708-7 http://loinc.org Plasma cells/Leukocytes in Synovial fluid 100709-5 http://loinc.org Hepatocellular carcinoma risk [Score] by GAAD 100710-3 http://loinc.org Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection 100711-1 http://loinc.org Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay 100712-9 http://loinc.org Brexpiprazole [Mass/volume] in Serum or Plasma 100713-7 http://loinc.org Cariprazine [Mass/volume] in Serum or Plasma 100714-5 http://loinc.org Guanfacine [Mass/volume] in Serum or Plasma 100715-2 http://loinc.org Prothipendyl [Mass/volume] in Serum or Plasma 100716-0 http://loinc.org Prostate specific Ag [Mass/volume] in DBS 100717-8 http://loinc.org FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method 100718-6 http://loinc.org Undersea and hyperbaric medicine Discharge summary 10071-9 http://loinc.org S' wave duration in lead AVL 100719-4 http://loinc.org Surgical oncology Discharge summary 100720-2 http://loinc.org Reproductive endocrinology and infertility Discharge summary 100721-0 http://loinc.org Community health care Discharge summary 100722-8 http://loinc.org Integrative medicine Discharge summary 100723-6 http://loinc.org Sports medicine Discharge summary 100724-4 http://loinc.org Diabetology Discharge summary 100725-1 http://loinc.org Optometry Discharge summary 100726-9 http://loinc.org Podiatry Discharge summary 10072-7 http://loinc.org S' wave duration in lead AVR 100727-7 http://loinc.org Chiropractic medicine Discharge summary 100728-5 http://loinc.org Cardiac surgery Discharge summary 100729-3 http://loinc.org Breastfeeding Discharge summary 100730-1 http://loinc.org Transplant surgery Discharge summary 100731-9 http://loinc.org Urgent care center Discharge summary 100732-7 http://loinc.org Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum 100733-5 http://loinc.org Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) 100734-3 http://loinc.org traMADol and Metabolites Panel - Urine by Confirmatory method 10073-5 http://loinc.org S' wave duration in lead I 100735-0 http://loinc.org Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes 100736-8 http://loinc.org Acylcarnitine Analysis Post Mortem in Specimen Document 100737-6 http://loinc.org Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma 100738-4 http://loinc.org Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma 100739-2 http://loinc.org Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma 1007-4 http://loinc.org Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells 100740-0 http://loinc.org Amylase.macromolecular [Presence] in Serum or Plasma 100741-8 http://loinc.org Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma 100742-6 http://loinc.org Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma 10074-3 http://loinc.org S' wave duration in lead II 100743-4 http://loinc.org Lipase.macromolecular [Presence] in Serum or Plasma 100744-2 http://loinc.org Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis 100745-9 http://loinc.org Chloride [Moles/volume] in Mixed venous blood 100746-7 http://loinc.org Glucose [Moles/volume] in Mixed venous blood 100747-5 http://loinc.org Legionella serogroup panel - Specimen 100748-3 http://loinc.org Legionella spp [Presence] in Specimen by NAA with probe detection 100749-1 http://loinc.org Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection 10075-0 http://loinc.org S' wave duration in lead III 100750-9 http://loinc.org Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection 100751-7 http://loinc.org Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma 100752-5 http://loinc.org Exacerbating factors - Reported 100753-3 http://loinc.org Alleviating factors - Reported 100754-1 http://loinc.org Platelet disorders multigene analysis in Blood or Tissue by Sequencing 100755-8 http://loinc.org Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing 100756-6 http://loinc.org Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing 100757-4 http://loinc.org Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing 100758-2 http://loinc.org Estimated lung age by based on clinical data 100759-0 http://loinc.org Inspiratory reserve [Volume] Respiratory system by Spirometry 100760-8 http://loinc.org XR Radius and Ulna - left Single view 100761-6 http://loinc.org PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 100762-4 http://loinc.org HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method 100763-2 http://loinc.org Mycobacterium sp comparative reaction interpretation Narrative 100764-0 http://loinc.org Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal 100765-7 http://loinc.org Homocysteine and methylmalonate and methylcitrate panel - DBS 100766-5 http://loinc.org Center for Epidemiologic Studies Depression Scale panel [CES-D] 100767-3 http://loinc.org Bothered by things that are not usually bothersome 10076-8 http://loinc.org S' wave duration in lead V1 100768-1 http://loinc.org Poor appetite 100769-9 http://loinc.org Unhappy even with help from my family or friends 100770-7 http://loinc.org Feeling just as good as others 100771-5 http://loinc.org Trouble focusing 100772-3 http://loinc.org Feeling depressed 100773-1 http://loinc.org Feeling everything is too much of an effort 100774-9 http://loinc.org Feeling hopeful about the future 100775-6 http://loinc.org Feeling life had been a failure 10077-6 http://loinc.org S' wave duration in lead V2 100776-4 http://loinc.org Feeling fearful 100777-2 http://loinc.org Restless sleep 100778-0 http://loinc.org Feeling happy 100779-8 http://loinc.org Quieter than usual 100780-6 http://loinc.org Feeling lonely 100781-4 http://loinc.org People were unfriendly 100782-2 http://loinc.org Enjoying life 100783-0 http://loinc.org Crying spells 10078-4 http://loinc.org S' wave duration in lead V3 100784-8 http://loinc.org Feeling sad 100785-5 http://loinc.org Feeling people dislike me 100786-3 http://loinc.org Lack of energy 100787-1 http://loinc.org Total Score CES-D 100788-9 http://loinc.org Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum 100789-7 http://loinc.org Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum 100790-5 http://loinc.org Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum 100791-3 http://loinc.org Hamster epithelium IgG Ab [Mass/volume] in Serum 10079-2 http://loinc.org S' wave duration in lead V4 100792-1 http://loinc.org Forsythia IgE Ab [Units/volume] in Serum 100793-9 http://loinc.org Testosterone [Mass/volume] in Body fluid 100794-7 http://loinc.org Follitropin [Units/volume] in Body fluid 100795-4 http://loinc.org S100 calcium binding protein B [Mass/volume] in Body fluid 100796-2 http://loinc.org Thyroglobulin [Mass/volume] in Body fluid 100797-0 http://loinc.org Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge 100798-8 http://loinc.org Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge 100799-6 http://loinc.org 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge 100-8 http://loinc.org Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) 10080-0 http://loinc.org S' wave duration in lead V5 100800-2 http://loinc.org 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge 100801-0 http://loinc.org 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge 100802-8 http://loinc.org 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge 100803-6 http://loinc.org 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge 100804-4 http://loinc.org Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge 100805-1 http://loinc.org Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge 100806-9 http://loinc.org Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge 100807-7 http://loinc.org Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge 100808-5 http://loinc.org Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge 100809-3 http://loinc.org Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge 100810-1 http://loinc.org Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge 100811-9 http://loinc.org Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge 100812-7 http://loinc.org Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge 100813-5 http://loinc.org Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge 100814-3 http://loinc.org Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge 100815-0 http://loinc.org Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge 100816-8 http://loinc.org Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge 100817-6 http://loinc.org Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge 10081-8 http://loinc.org S' wave duration in lead V6 100818-4 http://loinc.org Renin [Mass/volume] in Plasma --1st specimen post XXX challenge 100819-2 http://loinc.org Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge 1008-2 http://loinc.org Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma 100820-0 http://loinc.org Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge 100821-8 http://loinc.org National POLST form: portable medical order panel 100822-6 http://loinc.org Cardiopulmonary resuscitation orders 100823-4 http://loinc.org Initial portable medical treatment orders 100824-2 http://loinc.org Additional portable medical orders or instructions 100825-9 http://loinc.org Medically assisted nutrition orders 10082-6 http://loinc.org ST initial amplitude 6 ms in lead AVF 100826-7 http://loinc.org Portable medical order AndOr advance directive review 100827-5 http://loinc.org Portable medical order discussion participants 100828-3 http://loinc.org Portable medical order administrative information 100829-1 http://loinc.org Renin [Mass/volume] in Plasma --4th specimen post XXX challenge 100830-9 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge 100831-7 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge 100832-5 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge 100833-3 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge 10083-4 http://loinc.org ST initial amplitude 6 ms in lead AVL 100834-1 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge 100835-8 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge 100836-6 http://loinc.org Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge 100837-4 http://loinc.org Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge 100838-2 http://loinc.org Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge 100839-0 http://loinc.org Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma 100840-8 http://loinc.org IgE [Units/volume] in Body fluid 100841-6 http://loinc.org Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot 10084-2 http://loinc.org ST initial amplitude 6 ms in lead AVR 100842-4 http://loinc.org Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST 100843-2 http://loinc.org Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ 100844-0 http://loinc.org Liver fibrosis score in Serum or Plasma by Calculated.Agile4 100845-7 http://loinc.org Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) 100846-5 http://loinc.org Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay 100847-3 http://loinc.org Gas and ammonia panel - Arterial blood 100848-1 http://loinc.org Cell count and Differential panel - Amniotic fluid by Manual count 100849-9 http://loinc.org Leukocytes [#/volume] in Amniotic fluid by Manual count 100850-7 http://loinc.org Neutrophils [#/volume] in Amniotic fluid by Manual count 100851-5 http://loinc.org Other cells [#/volume] in Amniotic fluid by Manual count 100852-3 http://loinc.org NM Bones Views for metastasis W Sr-89 IV 100853-1 http://loinc.org NM Pericardial space Pericardial effusion 100854-9 http://loinc.org Lymphocytes/cells in Blood mononuclear cells by Immunoassay 100855-6 http://loinc.org CD3 cells/cells in Blood mononuclear cells 100856-4 http://loinc.org CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells 100857-2 http://loinc.org CD3+CD8+ (T8 suppressor) cells/cells in Blood mononuclear cells 100858-0 http://loinc.org Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide 10085-9 http://loinc.org ST initial amplitude 6 ms in lead I 100859-8 http://loinc.org Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide 100860-6 http://loinc.org Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide 100861-4 http://loinc.org Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide 100862-2 http://loinc.org Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide 100863-0 http://loinc.org Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide 100864-8 http://loinc.org Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method 100865-5 http://loinc.org Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection 100866-3 http://loinc.org Febrile antibody profile in Serum 10086-7 http://loinc.org ST initial amplitude 6 ms in lead II 100867-1 http://loinc.org Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay 100868-9 http://loinc.org Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method 100869-7 http://loinc.org Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method 100870-5 http://loinc.org Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method 100871-3 http://loinc.org Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method 100872-1 http://loinc.org Bacteria producing polysaccharide from sucrose [Presence] in Isolate 100873-9 http://loinc.org Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method 100874-7 http://loinc.org Basidiobolus sp [Presence] in Specimen 10087-5 http://loinc.org ST initial amplitude 6 ms in lead III 100875-4 http://loinc.org Fetal Heart Document limited US 100876-2 http://loinc.org Fetal Heart Document US 100877-0 http://loinc.org US Heart Transesophageal during surgery 100878-8 http://loinc.org Endoscopic ultrasound study Upper GI tract Document 100879-6 http://loinc.org US Guidance for cryoablation of Breast - right 100880-4 http://loinc.org US Guidance for cryoablation of Breast - left 100000-9 Health Info Pioneer+Father of LOINC 100001-7 Health Info Pioneer+Cofound LOINC 100002-5 Specimen care is maintained 100003-3 Team communication is maintained throughout care 100004-1 Demonstrates knowledge of the expected psychosocial responses to the procedure 100005-8 Demonstrates knowledge of nutritional management related to the procedure 100006-6 Demonstrates knowledge of medication management 100007-4 Demonstrates knowledge of pain management 10000-8 R wave dur L-AVR duración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-AVR 100008-2 Demonstrates knowledge of wound management 100009-0 Demonstrates knowledge of the procedure and expected results 100010-8 No injury related to procedure equipment, medical supplies, or instrumentation 100011-6 No injury related to an electrical source 100012-4 Participates in decisions affecting the patient's plan of care 100013-2 Participates in the discharge process 100014-0 Psychosocial health is maintained at or improved from baseline 100015-7 No injury related to positioning due to care or procedure 10001-6 R wave dur L-I duración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-I 100016-5 No injury related to a laser source 100017-3 Perioperative nursing data set outcomes panel [PNDS] 100018-1 Hospice care Note Verslag [bevinding] in {instelling} d.m.v. hospicezorg (document) 100019-9 ALK gene targeted mutation analysis, Blood or tissue specimen ALK gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire ALK-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100020-7 GNA11 gene targeted mutation analysis, Blood or tissue specimen GNA11 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire GNA11-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100021-5 GNAQ gene targeted mutation analysis, Blood or tissue specimen GNAQ gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire GNAQ-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100022-3 IDH1 gene targeted mutation analysis, Blood or tissue specimen IDH1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire IDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100023-1 IDH2 gene targeted mutation analysis, Blood or tissue specimen IDH2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire IDH2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 10002-4 R wave dur L-II duración de la onda R.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-II 100024-9 SETBP1 gene targeted mutation analysis, Blood or tissue specimen SETBP1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire SETBP1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100025-6 SRSF2 gene targeted mutation analysis, Blood or tissue specimen SRSF2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire SRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100026-4 MET gene targeted mutation analysis, Blood or tissue specimen MET gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire MET-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100027-2 SMAD4 gene targeted mutation analysis, Blood or tissue specimen SMAD4 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire SMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100028-0 FBXW7 gene targeted mutation analysis, Blood or tissue specimen FBXW7 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire FBXW7-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100029-8 Cancer related multigene analysis (cfDNA) Analyse multigénique en relation avec le cancer [Recherche] Plasma avec ADN libre circulant ; Document ; Biologie moléculaire Kankergerelateerde multigen-analyse [bevinding] in plasma.celvrij DNA d.m.v. moleculair genetisch onderzoek (document) 100030-6 Axis I: Temporal aspects score [Mainz Pain Staging System] 100031-4 Axis II: Spatial aspects score [Mainz Pain Staging System] 10003-2 R wave dur L-III duración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-III 100032-2 Axis III: Drug taking behavior score [Mainz Pain Staging System] 100033-0 Axis IV: Utilization of the health care system score [Mainz Pain Staging System] 100034-8 Provider of AED 100035-5 Exam finding location Chest 100036-3 Exam finding location Lung 100037-1 Patient contact disposition EMS unit 100038-9 Patient eval disposition EMS unit 100039-7 Crew disposition EMS unit 10004-0 R wave dur L-V1 duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-V1 100040-5 Pt transport disposition EMS unit 100041-3 Aminoglycosid-Empfindlichkeit Aminoglycosid [Empfindlichkeit] Susceptibility to Aminoglycoside Aminoglycoside [Sensibilité] Isolat ; Alphanumérique 100042-1 Atovaquon-Empfindlichkeit Susceptibility to Atovaquone Atovaquone [Sensibilité] Isolat ; Alphanumérique Atovaquone [gevoeligheid] in isolaat 100043-9 Azithromycin/Ethambutol-Empfindlichkeit Azithromycin+Ethambutol [Empfindlichkeit] Susceptibility to Azithromycin+Ethambutol Azithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique Azitromycine + ethambutol [gevoeligheid] in isolaat 100044-7 Cefcapene-Empfindlichkeit Cefcapen [Empfindlichkeit] Susceptibility to Cefcapene Cefcapene [Sensibilité] Isolat ; Alphanumérique Cefcapeen [gevoeligheid] in isolaat 100045-4 Cefozopran-Empfindlichkeit Susceptibility to Cefozopran Céfozopran [Sensibilité] Isolat ; Alphanumérique Cefozopran [gevoeligheid] in isolaat 100046-2 Cefquinom-Empfindlichkeit Susceptibility to Cefquinome Cefquinome [Sensibilité] Isolat ; Alphanumérique Cefquinome [gevoeligheid] in isolaat 100047-0 Cefteram-Empfindlichkeit Susceptibility to Cefteram Cefteram [Sensibilité] Isolat ; Alphanumérique Cefteram [gevoeligheid] in isolaat 100048-8 Clarithromycin/Ethambutol-Empfindlichkeit Clarithromycin+Ethambutol [Empfindlichkeit] Susceptibility to Clarithromycin+Ethambutol Clarithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique Clarithromycine + ethambutol [gevoeligheid] in isolaat 100049-6 Eravacycline-Empfindlichkeit Eravacyclin [Empfindlichkeit] Susceptibility to Eravacycline Éravacycline [Sensibilité] Isolat ; Alphanumérique Eravacycline [gevoeligheid] in isolaat 100050-4 Erythromycin/Ethambutol-Empfindlichkeit Erythromycin+Ethambutol [Empfindlichkeit] Susceptibility to Erythromycin+Ethambutol Érythromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique Erytromycine + ethambutol [gevoeligheid] in isolaat 100051-2 Ethambutol/rifAMPin-Empfindlichkeit Ethambutol+Rifampicin [Empfindlichkeit] Susceptibility to Ethambutol+rifAMPin Éthambutol+rifampicine [Sensibilité] Isolat ; Alphanumérique Ethambutol + rifampicine [gevoeligheid] in isolaat 100052-0 Flomoxef-Empfindlichkeit Flomoxef [Empfindlichkeit] Susceptibility to Flomoxef Flomoxef [Sensibilité] Isolat ; Alphanumérique Flomoxef [gevoeligheid] in isolaat 100053-8 Fluoroquinolon-Empfindlichkeit Fluorchinolon [Empfindlichkeit] Susceptibility to Fluoroquinolone Fluoroquinolone [Sensibilité] Isolat ; Alphanumérique Fluorchinolon [gevoeligheid] in isolaat 100054-6 Gamithromycin-Empfindlichkeit Susceptibility to Gamithromycin Gamithromycine [Sensibilité] Isolat ; Alphanumérique 100055-3 Optochin-Empfindlichkeit Optochin [Empfindlichkeit] Susceptibility to Optochin Optochine [Sensibilité] Isolat ; Alphanumérique Optochine [gevoeligheid] in isolaat 100056-1 Panipenem-Empfindlichkeit Panipenem [Empfindlichkeit] Susceptibility to Panipenem Panipénème [Sensibilité] Isolat ; Alphanumérique Panipenem [gevoeligheid] in isolaat 10005-7 R wave dur L-V2 duración de la onda R.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-V2 100057-9 Prothionamid-Empfindlichkeit Prothionamid [Empfindlichkeit] Susceptibility to Prothionamide Protionamide [Sensibilité] Isolat ; Alphanumérique Prothionamide [gevoeligheid] in isolaat 100058-7 Prulifloxacin-Empfindlichkeit Prulifloxacin [Empfindlichkeit] Susceptibility to Prulifloxacin Prulifloxacine [Sensibilité] Isolat ; Alphanumérique Prulifloxacine [gevoeligheid] in isolaat 100059-5 Rifapentin-Empfindlichkeit Rifapentin [Empfindlichkeit] Susceptibility to Rifapentine Rifapentine [Sensibilité] Isolat ; Alphanumérique Rifapentine [gevoeligheid] in isolaat 100060-3 Tildipirosin-Empfindlichkeit Susceptibility to Tildipirosin Tildipirosine [Sensibilité] Isolat ; Alphanumérique 100061-1 Tosufloxacin-Empfindlichkeit Tosufloxacin [Empfindlichkeit] Susceptibility to Tosufloxacin Tosufloxacine [Sensibilité] Isolat ; Alphanumérique Tosufloxacine [gevoeligheid] in isolaat 100062-9 SDOM panel 100063-7 Primary skin concern 100064-5 Itch severity RptPeriod Reported 10006-5 R wave dur L-V3 duración de la onda R.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-V3 100065-2 Satisfied with treatment 100066-0 Specular microscopy panel Endotheelcelmicroscopie panel in oog d.m.v. endotheelcelmicroscopie 100067-8 Eye Image magnification 100068-6 R eye Fixation point [Angle] 100069-4 L eye Fixation point [Angle] 100070-2 R cornea Cell density 100071-0 L cornea Cell density 100072-8 R cornea Coefficient of variation 10007-3 R wave dur L-V4 duración de la onda R.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-V4 100073-6 L cornea Coefficient of variation 100074-4 R cornea Hexagonality 100075-1 L cornea Hexagonality 100076-9 R cornea Endothelial cells counted 100077-7 L cornea Endothelial cells counted 100078-5 R cornea Endothelial cell area.min 100079-3 L cornea Endothelial cell area.min 100080-1 R cornea Endothelial cell area.max 10008-1 R wave dur L-V5 duración de la onda R.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-V5 100081-9 L cornea Endothelial cell area.max 100082-7 R cornea Endothelial cell area.mean 100083-5 L cornea Endothelial cell area.mean 100084-3 R cornea Cell area.sd 100085-0 L cornea Cell area.sd 100086-8 R cornea Analysis method 100087-6 Toxocara canis 24-35kD IgG antibody, Blood Toxocara canis 24-35kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxocara canis 24-35kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100088-4 Taenia solium larva Ab bands panel, Blood Taenia solium cysticerque Ac bandes panel [-] Sérum ; - ; Immunoblot Taenia solium larve As banden panel in serum d.m.v. immunoblotting 100089-2 Taenia solium larva 6-8kD antibody, Blood Taenia solium cysticerque 6-8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Taenia solium larve 6-8kD As [aanwezigheid] in serum d.m.v. immunoblotting 1000-9 DBG antibody, Blood Product Unit [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal: DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: DBG As [aanwezigheid] in serum of plasma^bloedproducteenheid DBG Ac SerPl BPU Ql 100090-0 Taenia solium larva 45kD antibody, Blood Taenia solium cysticerque 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Taenia solium larve 45kD As [aanwezigheid] in serum d.m.v. immunoblotting 100091-8 Trypanosoma cruzi antibody, Blood Trypanosoma cruzi Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse Trypanosoma cruzi As [eenheid/volume] in serum d.m.v. immunoassay 100092-6 Trypanosoma cruzi Ab bands panel, Blood Trypanosoma cruzi Ac bandes panel [-] Sérum ; - ; Immunoblot Trypanosoma cruzi As banden panel in serum d.m.v. immunoblotting 100093-4 Trypanosoma cruzi 15-16kD IgG antibody, Blood Trypanosoma cruzi 15-16kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100094-2 Trypanosoma cruzi 21-22kD IgG antibody, Blood Trypanosoma cruzi 21-22kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 21-22kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100095-9 Trypanosoma cruzi 27-28kD IgG antibody, Blood Trypanosoma cruzi 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100096-7 Trypanosoma cruzi 42kD IgG antibody, Blood Trypanosoma cruzi 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100097-5 Trypanosoma cruzi 45-47kD IgG antibody, Blood Trypanosoma cruzi 45-47kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100098-3 Trypanosoma cruzi 120-200kD IgG antibody, Blood Trypanosoma cruzi 120-200kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 120-200kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 10009-9 R wave dur L-V6 duración de la onda R.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R onda dur L-V6 100099-1 Trypanosoma cruzi 160kD IgG antibody, Blood Trypanosoma cruzi 160kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Trypanosoma cruzi 160kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100100-7 Fasciola sp IgG antibody, Blood Fasciola Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse Fasciola sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay 100101-5 Fasciola sp 8-9kD IgG antibody, Blood Fasciola 8-9kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Fasciola sp. 8-9kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100102-3 Fasciola sp 27-28kD IgG antibody, Blood Fasciola 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Fasciola sp. 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100103-1 Fasciola sp 60kD IgG antibody, Blood Fasciola 60kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Fasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100104-9 Fasciola sp 42kD IgG antibody, Blood Fasciola 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Fasciola sp. 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100105-6 Filaria IgG and IgM panel, Blood Filaria Ac IgG et IgM panel [-] Sérum ; - Filaria As.IgG & IgM panel in serum 100106-4 Filaria IgG antibody, Blood Filaria Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse Filaria As.IgG [aanwezigheid] in serum d.m.v. immunoassay 10010-7 R' wave Amp L-AVF amplitud de la onda R'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-AVF 100107-2 Leishmania sp IgG antibody, Blood Leishmania Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse Leishmania sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay 100108-0 Leishmania sp IgG antibody, Blood Leishmania Ac IgG [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse Leishmania sp. As.IgG [eenheid/volume] in serum d.m.v. immunoassay 100109-8 Leishmania sp Ab bands panel, Blood Leishmania Ac bandes panel [-] Sérum ; - ; Immunoblot Leishmania sp. As banden panel in serum d.m.v. immunoblotting 100110-6 Leishmania sp 14kD IgG antibody, Blood Leishmania 14 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Leishmania sp. 14kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100111-4 Leishmania sp 16kD IgG antibody, Blood Leishmania 16 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Leishmania sp. 16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting 100112-2 Fasciola sp Ab bands panel, Blood Fasciola Ac bandes panel [-] Sérum ; - ; Immunoblot Fasciola sp. As-banden panel in serum d.m.v. immunoblotting 100113-0 Helicobacter pylori Ab panel, Blood Helicobacter pylori Ac panel [-] Sérum ; - Helicobacter pylori As panel in serum 100114-8 Toxoplasma gondii 30kD antibody, Blood Toxoplasma gondii 30kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting 10011-5 R' wave Amp L-AVL amplitud de la onda R'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-AVL 100115-5 Toxoplasma gondii 31kD antibody, Blood Toxoplasma gondii 31kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxoplasma gondii 31kD As [aanwezigheid] in serum d.m.v. immunoblotting 100116-3 Toxoplasma gondii 33kD antibody, Blood Toxoplasma gondii 33kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting 100117-1 Toxoplasma gondii 40kD antibody, Blood Toxoplasma gondii 40kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxoplasma gondii 40kD As [aanwezigheid] in serum d.m.v. immunoblotting 100118-9 Toxoplasma gondii 41kD antibody, Blood Toxoplasma gondii 41kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting 100119-7 Toxoplasma gondii 45kD antibody, Blood Toxoplasma gondii 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Toxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting 100120-5 Chlamydia trachomatis Ab panel, Blood Chlamydia trachomatis Ac panel [-] Sérum ; - Chlamydia trachomatis As panel in serum 100121-3 Chlamydia trachomatis IgA-Antikörper [Nachweis] in Serum mittels Immunoassay Chlamydia trachomatis IgA antibody, Blood Chlamydia trachomatis Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse Chlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay Chlamydia trachomatis Антитіла.IgA ІА (Свтк) [НвнПор] 100122-1 C. pneumoniae Ab panel, Blood Chlamydia pneumoniae Ac panel [-] Sérum ; - Chlamydophila pneumoniae As panel in serum 10012-3 R' wave Amp L-AVR amplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-AVR 100123-9 Chlamydophila pneumoniae IgA antibody, Blood Chlamydia pneumoniae Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse Chlamydophila pneumoniae As.IgA [aanwezigheid] in serum d.m.v. immunoassay 100124-7 Chlamydophila pneumoniae IgA antibody, Blood Chlamydia pneumoniae Ac IgA [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse Chlamydophila pneumoniae As.IgA [eenheid/volume] in serum d.m.v. immunoassay 100125-4 C. psittaci Ab panel, Blood Chlamydia psittaci Ac panel [-] Sérum ; - Chlamydophila psittaci As panel in serum 100126-2 Bordetella pertussis Ab.IgG panel, Blood Bordetella pertussis Ac IgG panel [-] Sérum ; - Bordetella pertussis As.IgG panel in serum 100127-0 Campylobacter sp Ab panel, Blood Campylobacter Ac panel [-] Sérum ; - Campylobacter sp. As panel in serum 100128-8 Cryptococcus sp Ag panel, Blood Cryptococcus Ag panel [-] Sérum ; - Cryptococcus sp. Ag panel in serum 100129-6 Schistosoma sp antibody, Blood Schistosoma Ac [Titre] Sérum ; Semi-Quantitatif ; Hémagglutination Schistosoma sp. As [titer] in serum d.m.v. hemagglutinatie 100130-4 Schistosoma mansoni antibody, Blood Schistosoma mansoni Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma mansoni As [aanwezigheid] in serum d.m.v. immunoblotting 10013-1 R' wave Amp L-I amplitud de la onda R'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de la onda R '. I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-I 100131-2 Schistosoma sp 8kD antibody, Blood Schistosoma 8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 8kD As [aanwezigheid] in serum d.m.v. immunoblotting 100132-0 Schistosoma sp 9kD antibody, Blood Schistosoma 9kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting 100133-8 Schistosoma sp 10kD antibody, Blood Schistosoma 10kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 10kD As [aanwezigheid] in serum d.m.v. immunoblotting 100134-6 Schistosoma sp 11kD antibody, Blood Schistosoma 11kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting 100135-3 Schistosoma sp 12-13kD antibody, Blood Schistosoma 12-13kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 12-13kD As [aanwezigheid] in serum d.m.v. immunoblotting 100136-1 Schistosoma sp 14-15kD antibody, Blood Schistosoma 14-15kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting 100137-9 Schistosoma sp 15-16kD antibody, Blood Schistosoma 15-16kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 15-16kD As [aanwezigheid] in serum d.m.v. immunoblotting 100138-7 Schistosoma sp 18-19kD antibody, Blood Schistosoma 18-19kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting 100139-5 Schistosoma sp 22-24kD antibody, Blood Schistosoma 22-24kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 22-24kD As [aanwezigheid] in serum d.m.v. immunoblotting 100140-3 Schistosoma sp 30-34kD antibody, Blood Schistosoma 30-34kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 30-34kD As [aanwezigheid] in serum d.m.v. immunoblotting 100141-1 Schistosoma sp 65kD antibody, Blood Schistosoma 65kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 65kD As [aanwezigheid] in serum d.m.v. immunoblotting 100142-9 Schistosoma sp 70kD antibody, Blood Schistosoma 70kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting 100143-7 Schistosoma sp 80kD antibody, Blood Schistosoma 80kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 80kD As [aanwezigheid] in serum d.m.v. immunoblotting 100144-5 Schistosoma sp 95kD antibody, Blood Schistosoma 95kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting 100145-2 Schistosoma sp 110kD antibody, Blood Schistosoma 110kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting 100146-0 Schistosoma sp 120kD antibody, Blood Schistosoma 120kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot Schistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting 100147-8 Toxoplasma gondii Ab bands panel, Blood Toxoplasma gondii Ac bandes panel [-] Sérum ; - ; Immunoblot Toxoplasma gondii As banden panel in serum d.m.v. immunoblotting 100148-6 Schistosoma sp Ab bands panel, Blood Schistosoma Ac bandes panel [-] Sérum ; - ; Immunoblot Schistosoma sp. As banden panel in serum d.m.v. immunoblotting 10014-9 R' wave Amp L-II amplitud de la onda R'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-II 100149-4 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel, Urine+Blood 6-oxo-pipéridine-2-carboxylate et 6(R+S)-oxo-propylpipéridine-2-carboxylate panel [-] Urine+Sérum/Plasma ; - 6-oxo-piperidine-2-carboxylaat & 6(R+S)-oxo-propylpiperidine-2-carboxylaat in urine en serum of plasma 100150-2 6(R+S)-oxo-propylpiperidine-2-carboxylate, Blood 6(R+S)-oxo-propylpipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique 6(R+S)-oxo-propylpiperidine-2-carboxylaat [mol/volume] in plasma 100151-0 6-oxo-piperidine-2-carboxylate, Blood 6-oxo-pipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique 6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma 100152-8 6-oxo-piperidine-2-carboxylate/Creatinine, Urine 6-oxo-pipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique 6-oxo-piperidine-2-carboxylaat/creatinine [molaire verhouding] in urine 100153-6 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine 6(R+S)-oxo-propylpipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique 6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine 100154-4 Collection supervision level, Specimen Niveau de supervision du recueil [Recherche] Prélèvement ; Résultat nominal 100155-1 L cornea Analysis method 10015-6 R' wave Amp L-III amplitud de la onda R'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-III 100156-9 SARS-CoV-2 (COVID-19)-Variante [Typ] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion SARS-CoV-2 (COVID-19) variant, Specimen Coronavirus SARS-CoV-2 variant [Type] Milieux divers ; Résultat nominal ; PCR amplification de cible SARS-CoV-2-variant [type] d.m.v. probe-detectie 100157-7 SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels Sequenzierung SARS-CoV-2 (COVID-19) lineage, Specimen Coronavirus SARS-CoV-2 lignée [Type] Milieux divers ; Résultat nominal ; Séquençage SARS-CoV-2 lineage [type] d.m.v. sequencing 100158-5 Albumin, Urine Albumine [Masse/Volume] Temps non précisé ; Urine ; Numérique ; Limite de détection<=20mg/L Albumine [massa/volume] in urine (verzamelduur niet gespecificeerd) d.m.v. detectielimiet <= 20 mg/L 100159-3 Knee Society Score pre-op panel [Knee Society Score] 100160-1 Knee replacement 100161-9 Charnley Functional Classification 100162-7 Alignment W Stand Knee XR 100163-5 Knee medial AndOr lateral instability W full extension 10016-4 R' wave Amp L-V1 amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-V1 100164-3 Knee AP instability W 90 degree flexion 100165-0 Knee Qn 100166-8 Flexion contracture range Knee 100167-6 Extensor lag range Knee 100168-4 Knee pain severity with level walking 100169-2 Knee pain severity with stairs or inclines 1001-7 DBG antibody, Donor Blood [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal: DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: DBG As [aanwezigheid] in serum of plasma^donor DBG Ac SerPl Donr Ql 100170-0 Knee feels normal 100171-8 Satisfaction with level of knee pain while sitting 10017-2 R' wave Amp L-V2 amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-V2 100172-6 Satisfaction with level of knee pain while lying in bed 100173-4 Satisfaction with knee function while getting out of bed 100174-2 Satisfaction with knee function while performing light household duties 100175-9 Satisfaction with knee function while performing recreational activities 100176-7 Expect surgery to relieve pain 100177-5 Expect surgery will improve ability to perform activities of daily living 100178-3 Expect surgery will improve ability to perform leisure, recreational, or sports activities 100179-1 Walk without assistive mobility devices 10018-0 R' wave Amp L-V3 amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-V3 100180-9 Assistive mobility devices used 100181-7 Assistive mobility devices used due to health condition 100182-5 Duration of standing before sitting due to knee discomfort 100183-3 Duration of walking before stopping due to knee discomfort 100184-1 How bothersome is knee when walking on an uneven surface 100185-8 How bothersome is knee when turning or pivoting leg 100186-6 How bothersome is knee when climbing up or down a flight of stairs 100187-4 How bothersome is knee when getting up from a low seat without armrests 100188-2 How bothersome is knee when getting into or out of a car 100189-0 How bothersome is knee when moving laterally 100190-8 How bothersome is knee when climbing a ladder or step stool 100191-6 How bothersome is knee when carrying a bag for one block 100192-4 How bothersome is knee when squatting 100193-2 How bothersome is knee when kneeling 100194-0 How bothersome is knee when running 100195-7 Pain severity--during activity 100196-5 Pre-op total score [Knee Society Score] 100197-3 Exercise activity and pain severity panel 10019-8 R' wave Amp L-V4 amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-V4 100198-1 Pre-op objective knee indicators score [Knee Society Score] 100199-9 Pre-op symptoms score [Knee Society Score] 100200-5 Pre-op patient expectations score [Knee Society Score] 100201-3 Pre-op functional activities score [Knee Society Score] 100202-1 Pre-op discretionary knee activities score [Knee Society Score] 100203-9 Knee Society Score post-op panel [Knee Society Score] 100204-7 Accuracy of pre-surgery expectations of pain relief 100205-4 Accuracy of pre-surgery expectations to perform activities of daily living 10020-6 R' wave Amp L-V5 amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-V5 100206-2 Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities 100207-0 Post-op total score [Knee Society Score] 100208-8 Post-op objective knee indicators score [Knee Society Score] 100209-6 Post-op symptoms score [Knee Society Score] 100210-4 Post-op patient expectations score [Knee Society Score] 100211-2 Post-op functional activities score [Knee Society Score] 100212-0 Post-op discretionary knee activities score [Knee Society Score] 100213-8 Prostate cancer multigene analysis, Blood or tissue specimen Analyse multigénique du cancer de la prostate [Recherche] Sang/Tissu ; Document ; Biologie moléculaire Multigen-analyse op prostaatkanker [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) 10021-4 R' wave Amp L-V6 amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG R' onda Amp L-V6 100214-6 Dental model prior auth Doc 100215-3 Episode of care med rec Doc Transpl surg Verslag van zorgepisode [bevinding] d.m.v. transplantatiechirurgie (document) 100216-1 Surgical synoptic report Beknopt rapport [bevinding] d.m.v. chirurgie (tekstueel) 100217-9 Synoptic report Surg Onc 100218-7 Surg onc colon CA synoptic rep 100219-5 Surg onc melanoma CA synoptic rep 100220-3 Surg onc breast CA synoptic rep 100221-1 Surg onc thyroid CA synoptic rep 10022-2 R' wave dur L-AVF duración de la onda R'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-AVF 100222-9 Surg onc pancreas CA synoptic rep 100223-7 Retina Phys find 100224-5 Cardiac LV SWM Pnl LV US 100225-2 Bone density QUS 100226-0 Sm bowel capsule endo study Doc 100227-8 Colon capsule endo study Doc 100228-6 UGI capsule endo study Doc 100229-4 Endo US study Doc 10023-0 R' wave dur L-AVL duración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-AVL 100230-2 Routine prenatal pnl 100231-0 EBUS study 100232-8 Impacts of Events Scale-Revised panel 100233-6 Reminders brought back feelings about adverse event 100234-4 Trouble staying asleep 100235-1 Other things triggered persistent thoughts about adverse event 100236-9 Felt irritable AndOr angry 100237-7 Avoided getting upset when unintentionally thought about adverse event 100238-5 Thought about adverse event unintentionally 100239-3 Felt as if adverse event did not happen 100240-1 Avoided reminders of adverse event 100241-9 Experienced mental images of adverse event 100242-7 Easily startled 100243-5 Tried to not think of adverse event 100244-3 Aware of feelings about adverse event, but did not address them 100245-0 Feelings about adverse event were numb 100246-8 Acted or felt the same as during adverse event 100247-6 Trouble falling asleep 10024-8 R' wave dur L-AVR duración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-AVR 100248-4 Waves of strong feelings about adverse event 100249-2 Tried to remove adverse event from memory 1002-5 DBG antibody, Blood [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: DBG As [aanwezigheid] in serum of plasma DBG Ac SerPl Ql 100250-0 Trouble concentrating 100251-8 Reminders of adverse event caused physical reactions 100252-6 Had dreams about adverse event 100253-4 Felt watchful and on-guard 100254-2 Tried not to talk about adverse event 10025-5 R' wave dur L-I duración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-I 100255-9 Total score [Impact of Event Scale-Revised] 100256-7 Fallen in last 6Mo 100257-5 Feel unsteady when standing or walking 100258-3 History of fall related injury 100259-1 Aware of tactile sensations 100260-9 Easy to describe thoughts AndOr feelings 100261-7 Critical of own thoughts AndOr feelings 100262-5 Able to notice distressing thoughts AndOr feelings without having to react 10026-3 R' wave dur L-II duración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-II 100263-3 Easily distracted 100264-1 Able to notice thoughts AndOr feelings without being overwhelmed 100265-8 Aware of dietary intake impact on self 100266-6 Difficult to describe thoughts AndOr feelings 100267-4 Aware of auditory stimuli 100268-2 Able to avoid immediate reaction in difficult situations 100269-0 Do things without paying attention 100270-8 Recover quickly from distressing thoughts AndOr images 10027-1 R' wave dur L-III duración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-III 100271-6 Aware of olfactory stimuli 100272-4 Aware of visual stimuli 100273-2 Aware of emotions affect on thoughts AndOr behavior 100274-0 Observing score [FFMQ] 100275-7 Describing score [FFMQ] 100276-5 Acting with awareness score [FFMQ] 100277-3 Nonjudging score [FFMQ] 100278-1 Nonreactivity score [FFMQ] 100279-9 Total score [FFMQ] 100280-7 Five Facet Mindfulness Questionnaire panel [FFMQ] 100281-5 D antibody, Blood RH1 (D) anticorps [Arbitraire/Volume] Sérum/Plasma ; Numérique D As [eenheid/volume] in serum of plasma 100282-3 Vaccine exemption cert 100283-1 Harris Hip Score panel [Harris Hip Score] 100284-9 Walking - functional ability 100285-6 Comfortable seated position 100286-4 Able to board public transportation 100287-2 Put on shoes and socks 100288-0 Absence of deformity score [Harris Hip Score] 10028-9 R' wave dur L-V1 duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-V1 100289-8 Absence of hip deformity measurements 100290-6 Range of motion score [Harris Hip Score] 100291-4 Total score [Harris Hip Score] 100292-2 Pre-op patient satisfaction score [Knee Society Score] 100293-0 Hip Flexion range of motion 100294-8 Hip Abduction range of motion 100295-5 Hip Adduction range of motion 100296-3 Hip External rotation range of motion 10029-7 R' wave dur L-V2 duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-V2 100297-1 Hip Internal rotation range of motion 100298-9 Rep count 100299-7 Post-op patient satisfaction score [Knee Society Score] 100300-3 End time 100301-1 Start time 100302-9 Time start/end panel Spec 100303-7 Condition certainty of presence 100304-5 Flights climbed RptPeriod 10030-5 R' wave dur L-V3 duración de la onda R'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-V3 100305-2 IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrow IDH1 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire IDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek 100306-0 IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrow IDH2 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire IDH2-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek 100307-8 Behavioral screening elder mistreatment 100308-6 Need help getting to essential places 100309-4 Activity support person 100310-2 Reliability of support person 100311-0 Need help to make sure there is enough food, medicines or any other things needed in house 100312-8 Person or persons that makes sure there is enough food, medicines or any other things needed in house 10031-3 R' wave dur L-V4 duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-V4 100313-6 Need help with household things such as cook meals, help feed, or provide correct medicines each day 100314-4 Need help with house cleaning or yard work 100315-1 Need help getting out of bed, showered, or dressed 100316-9 Need help to make sure bills get paid 100317-7 Relationship of usual support person for daily activities 100318-5 Have help with finances AndOr financial decisions 100319-3 Relationship of financial support person 100320-1 Financial support person usually asks for permission before making decisions 10032-1 R' wave dur L-V5 duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-V5 100321-9 Financial support person usually makes good decisions about finances 100322-7 Have access to paperwork for financial decisions made 100323-5 Financial support person forged signature 100324-3 Coercion of financial support person for signing a document in order to get money or possessions 100325-0 Experienced theft by support person 100326-8 Money spent or property sold without permission 100327-6 Stranger forged signature for financial gain 100328-4 Stranger forced document signature for financial gain 100329-2 Feared for safety due to verbal attack 1003-3 Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood prueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: Prueba de antiglobulina indirecta, reactivo específico del complemento: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: Test indirect à l'antiglobuline (TIA) complément spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif Indirecte antiglobulinetest.complement-specifiek reagent [aanwezigheid] in serum of plasma IAT Comp-Sp Reag SerPl Ql 100330-0 Felt humiliated due to ridicule 100331-8 Coerced to do something 100332-6 Ignored by close friend or relative for extended period 100333-4 Physically hit or threatened 100334-2 Been physically hurt with some degree of injury 100335-9 Coerced sexual activity 100336-7 Coerced touching of private body parts of self or others 100337-5 Coerced to undress or expose private body area 100338-3 Photographed in any degree of nudity without consent 10033-9 R' wave dur L-V6 duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG R' onda dur L-V6 100339-1 Experienced attempted physical restraint 100340-9 Range of motion panel Hip 100341-7 Rötelnvirus Antikörper-Index Röteln-Virus IgG-Antikörperindex [Einheiten/Volumen] in Serum und Liquor Rubella virus IgG index, Serum+Cerebrospinal fluid Rubéole virus Ac IgG index [Arbitraire/Volume] Sérum+Liquide céphalorachidien ; Numérique Rubellavirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis 100342-5 Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MS Volatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gas Composés organiques volatiles associés à l'infection SARS-CoV-2 [Présence/Seuil] Gaz expiré ; Qualitatif ; GC-MS Vluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie 100343-3 Influenza-Virus B RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion Influenza B (Flu B), Saliva Influenza virus B ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cible Influenzavirus B RNA [aanwezigheid] in speeksel d.m.v. probe-detectie 100344-1 Influenza-Virus A RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion Influenza A (Flu A), Saliva Influenza virus A ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cible Influenzavirus A RNA [aanwezigheid] in speeksel d.m.v. probe-detectie 100345-8 Influenza-Virus A und Influenza-Virus B und SARS-CoV-2 (COVID-19) RNA (Liste) - Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Specimen Influenza virus A et B et Coronavirus SARS-Cov-2 ARN panel [-] Milieux divers ; - ; PCR amplification de cible Influenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie 100346-6 Clotting Time FIBTEM Clotting time.extrinsic coagulation system activated.platelets inhibited, Blood Temps de coagulation (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle 10034-7 S wave Amp L-AVF amplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-AVF 100347-4 Clot Formation Time FIBTEM Clot formation.extrinsic coagulation system activated.platelets inhibited, Blood Temps de formation du caillot (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle 100348-2 MELDNa score 100349-0 DOP Penis ves W vasodilator IV 100350-8 Sesamum indicum 1 allergy test Sésame (graine) 1 Ac IgE [Arbitraire/Volume] Sérum ; Numérique Sesamum indicum 1 As.IgE [eenheid/volume] in serum 100351-6 Pioglitazone, Blood Pioglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif Pioglitazon [aanwezigheid] in serum of plasma 100352-4 Rosiglitazone, Blood Rosiglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif Rosiglitazon [aanwezigheid] in serum of plasma 100353-2 Norwalk Community Health Center Screening Tool [NCHC] 10035-4 S wave Amp L-AVL amplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-AVL 100354-0 Frequency of participating in multi-modal communication without assistance 100355-7 Frequency of participating in spoken language expression communication without assistance 100356-5 Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, Specimen Chlamydia trachomatis et Neisseria gonorrhoeae et Trichomonas vaginalis ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie 100357-3 Naloxone, Umbilical cord tissue Naloxone [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage Naloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening 100358-1 Phentermine, Umbilical cord tissue Phentermine [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage Fentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening 100359-9 Gliadin 33 mer peptide, Stool Gliadine 33-mer peptide [Masse/Volume] Selle ; Numérique ; Immunoanalyse Gliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay 100360-7 Brief Resilience Scale panel [BRS] 100361-5 Quickly recover from bad events 10036-2 S wave Amp L-AVR amplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-AVR 100362-3 Difficulty making it through stressful events 100363-1 Easily recover from a stressful event 100364-9 Difficulty recovering from bad events 100365-6 Easily recover from difficulties 100366-4 Lengthy recovery from setbacks 100367-2 Total Score BRS 100368-0 Amino Acids Urea Cycle Panel, Blood Acides aminés du cycle de l'urée panel [-] Sérum/Plasma ; - ; LC/MS/MS Aminozuren ureumcyclus panel in serum of plasma d.m.v. LC/MS/MS 100369-8 NM Thyroid Views W Tl-201 IV 10037-0 S wave Amp L-I amplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de la onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-I 100370-6 Orthopoxvirus DNA [Nachweis oder Identität] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Orthopoxvirus, Specimen Orthopoxvirus ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible Orthopoxvirus DNA [identificator] d.m.v. probe-detectie 100371-4 Titin antibody, Blood Titine anticorps [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse 100372-2 Abiraterone, Blood Abiratérone [Masse/Volume] Sérum/Plasma ; Numérique Abirateron [massa/volume] in serum of plasma 100373-0 Agar- agar IgG antibody Eucheuma Ac IgG [Arbitraire/Volume] Sérum ; Numérique Eucheuma As.IgG [eenheid/volume] in serum 100374-8 Aloe vera IgG antibody Aloe vera Ac IgG [Arbitraire/Volume] Sérum ; Numérique Aloë vera As.IgG [eenheid/volume] in serum 100375-5 Anise IgG antibody Anis Ac IgG [Arbitraire/Volume] Sérum ; Numérique Pimpinella anisum As.IgG [eenheid/volume] in serum 100376-3 Bambusa vulgaris IgG antibody Bambou commun Ac IgG [Arbitraire/Volume] Sérum ; Numérique Bambusa vulgaris As.IgG [eenheid/volume] in serum 100377-1 Goat cheese IgG antibody Fromage de chèvre Ac IgG [Arbitraire/Volume] Sérum ; Numérique Geitenkaas As.IgG [eenheid/volume] in serum 100378-9 Sheep cheese IgG antibody Fromage de brebis Ac IgG [Arbitraire/Volume] Sérum ; Numérique Schapenkaas As.IgG [eenheid/volume] in serum 100379-7 Leeks IgG antibody Poireau vivace Ac IgG [Arbitraire/Volume] Sérum ; Numérique Allium ampeloprasum As.IgG [eenheid/volume] in serum 100380-5 Red cabbage IgG antibody Chou rouge Ac IgG [Arbitraire/Volume] Sérum ; Numérique Brassica rubra As.IgG [eenheid/volume] in serum 100381-3 Mentha balsamea Wild IgG antibody Menthe poivrée hybride Ac IgG [Arbitraire/Volume] Sérum ; Numérique Pepermunt As.IgG [eenheid/volume] in serum 100382-1 FDA insert REMS addressed risk 100383-9 Affenpockenvirus-DNA ql. /Sondermaterial PCR Affenpocken-Virus DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Monkeypox virus, Specimen Monkeypox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Mpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie 100384-7 Rapeseed IgG antibody Chou champêtre Ac IgG [Arbitraire/Volume] Sérum ; Numérique Brassica rapa As.IgG [eenheid/volume] in serum 100385-4 Corn salad IgG antibody Mâche Ac IgG [Arbitraire/Volume] Sérum ; Numérique Valerianella locusta As.IgG [eenheid/volume] in serum 100386-2 Rosemary IgG antibody Romarin Ac IgG [Arbitraire/Volume] Sérum ; Numérique Rosmarinus officinalis As.IgG [eenheid/volume] in serum 100387-0 Poppy seed IgG antibody Pavot (graine) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Papaver somniferum As.IgG [eenheid/volume] in serum 10038-8 S wave Amp L-II amplitud de la onda S.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-II 100388-8 Cocoa IgG antibody Cacao Ac IgG [Arbitraire/Volume] Sérum ; Numérique Theobroma cacao As.IgG [eenheid/volume] in serum 100389-6 Pistachio IgG antibody Pistache Ac IgG [Arbitraire/Volume] Sérum ; Numérique Pistacia vera As.IgG [eenheid/volume] in serum 100390-4 Sunflower seed IgG antibody Tournesol (graine) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Helianthus annuus zaad As.IgG [eenheid/volume] in serum 100391-2 Dates IgG antibody Datte Ac IgG [Arbitraire/Volume] Sérum ; Numérique Phoenix dactylifera As.IgG [eenheid/volume] in serum 100392-0 Duck meat IgG antibody Canard (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Eendenvlees As.IgG [eenheid/volume] in serum 100393-8 Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibody Allergène de champigons macroscopiques mix2 (Xerocomus, Boletus) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Paddenstoelallergenen mix 2 (Xerocomus + Boletus) As.IgG [eenheid/volume] in serum 100394-6 Decapod crustaceans IgG antibody Astacoidea Ac IgG [Arbitraire/Volume] Sérum ; Numérique Astacoidea As.IgG [eenheid/volume] in serum 100395-3 Carob IgG antibody Caroube Ac IgG [Arbitraire/Volume] Sérum ; Numérique Ceratonia siliqua As.IgG [eenheid/volume] in serum 10039-6 S wave Amp L-III amplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-III 100396-1 Brassica napus IgG antibody Colza Ac IgG [Arbitraire/Volume] Sérum ; Numérique Brassica napus As.IgG [eenheid/volume] in serum 100397-9 Goat Meat IgG antibody Bouquetin Ac IgG [Arbitraire/Volume] Sérum ; Numérique Geitenvlees As.IgG [eenheid/volume] in serum 100398-7 Goose meat IgG antibody Oie (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Ganzenvlees As.IgG [eenheid/volume] in serum 100399-5 Ostrich meat IgG antibody Autruche (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Struisvogelvlees As.IgG [eenheid/volume] in serum 100400-1 Quail meat IgG antibody Caille (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Kwartelvlees As.IgG [eenheid/volume] in serum 100401-9 Rabbit meat IgG antibody Lapin (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Konijnenvlees As.IgG [eenheid/volume] in serum 100402-7 Venison meat IgG antibody Venaison (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Hertenvlees As.IgG [eenheid/volume] in serum 100403-5 Guineafowl IgG antibody Pintade Ac IgG [Arbitraire/Volume] Sérum ; Numérique Parelhoen As.IgG [eenheid/volume] in serum 10040-4 S wave Amp L-V1 amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-V1 100404-3 Horse meat IgG antibody Cheval (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Paardenvlees As.IgG [eenheid/volume] in serum 100405-0 Kefir IgG antibody Kefir Ac IgG [Arbitraire/Volume] Sérum ; Numérique Kefir As.IgG [eenheid/volume] in serum 100406-8 Butter IgG antibody Beurre Ac IgG [Arbitraire/Volume] Sérum ; Numérique Boter As.IgG [eenheid/volume] in serum 100407-6 Camembert cheese IgG antibody Fromage camembert Ac IgG [Arbitraire/Volume] Sérum ; Numérique Camembert As.IgG [eenheid/volume] in serum 100408-4 Emmental cheese IgG antibody Fromage emmental Ac IgG [Arbitraire/Volume] Sérum ; Numérique Emmentaler kaas As.IgG [eenheid/volume] in serum 100409-2 Processed cheese IgG antibody Fromage fondu Ac IgG [Arbitraire/Volume] Sérum ; Numérique Smeltkaas As.IgG [eenheid/volume] in serum 1004-1 Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells prueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: Test de antiglobulina directo, reactivo específico del complemento: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: Test direct à l'antiglobuline (EDA) complément spécifique [Présence/Seuil] Érythrocytes ; Qualitatif Directe antiglobulinetest.complement specifiek reagens [aanwezigheid] in erytrocyten DAT Comp-Sp Reag RBC Ql 100410-0 Curd cheese IgG antibody Fromage blanc Ac IgG [Arbitraire/Volume] Sérum ; Numérique Kwark As.IgG [eenheid/volume] in serum 100411-8 Sugar beet IgG antibody Betterave sucrière Ac IgG [Arbitraire/Volume] Sérum ; Numérique Bèta-vulgaris As.IgG [eenheid/volume] in serum 10041-2 S wave Amp L-V2 amplitud de la onda S.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-V2 100412-6 Chinese cabbage IgG antibody Chou chinois Ac IgG [Arbitraire/Volume] Sérum ; Numérique Chinese kool As.IgG [eenheid/volume] in serum 100413-4 Fennel fresh IgG antibody Fenouil Ac IgG [Arbitraire/Volume] Sérum ; Numérique Foeniculum vulgare vers As.IgG [eenheid/volume] in serum 100414-2 Gourd IgG antibody Cucurbitaceae Ac IgG [Arbitraire/Volume] Sérum ; Numérique Genera in Cucurbitaceae As.IgG [eenheid/volume] in serum 100415-9 Kale IgG antibody Chou frisé Ac IgG [Arbitraire/Volume] Sérum ; Numérique Brassica oleracea var. Borecole As.IgG [eenheid/volume] in serum 100416-7 Savoy cabbage IgG antibody Chou de Milan [Arbitraire/Volume] Sérum ; Numérique Brassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum 100417-5 Vitis sp leaf IgG antibody Feuille de vigne Ac IgG [Arbitraire/Volume] Sérum ; Numérique Blad van Vitis sp. As.IgG [eenheid/volume] in serum 100418-3 Liquorice IgG antibody Réglisse Ac IgG [Arbitraire/Volume] Sérum ; Numérique Glycyrrhiza glabra As.IgG [eenheid/volume] in serum 100419-1 Snow pea IgG antibody Pois gourmand Ac IgG [Arbitraire/Volume] Sérum ; Numérique Pisum sativum var. saccharatum As.IgG [eenheid/volume] in serum 10042-0 S wave Amp L-V3 amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-V3 100420-9 Fava bean IgG antibody Fève Ac IgG [Arbitraire/Volume] Sérum ; Numérique Vicia faba As.IgG [eenheid/volume] in serum 100421-7 Chick pea IgG antibody Pois chiche Ac IgG [Arbitraire/Volume] Sérum ; Numérique Cicer arietinus As.IgG [eenheid/volume] in serum 100422-5 Chicory IgG antibody Chicorée sauvage Ac IgG [Arbitraire/Volume] Sérum ; Numérique Cichorium intybus As.IgG [eenheid/volume] in serum 100423-3 Button + oyster + Shiitaki + chanterelle mushroom IgG antibody (Champignon de Paris+pleurote+lentin du chêne+catharelle) Ac IgG [Arbitraire/Volume] Sérum ; Numérique Paddenstoelallergenen mix 1 (Agaricus bisporus + Pleurotus ostreatus + Lentinula edodes + Cantharellus) As.IgG [eenheid/volume] in serum 100424-1 8(9)-Cholestenol, Blood 8(9)-cholesténol [Masse/Volume] Sérum/Plasma ; Numérique 8(9)-cholestenol [massa/volume] in serum of plasma 100425-8 DiHydro T-Mas, Blood Dihydro T-Mas [Masse/Volume] Sérum/Plasma ; Numérique DiHydro T-Mas [massa/volume] in serum of plasma 100426-6 Squalene, Blood Squalène [Masse/Volume] Sérum/Plasma ; Numérique 100427-4 Stigmasterol, Blood Stigmastérol [Masse/Volume] Sérum/Plasma ; Numérique Stigmasterol [massa/volume] in serum of plasma 100428-2 Carnitine free and total and acylcarnitine panel, Urine Carnitine libre et totale et acylcarnitine panel [-] Urine ; - Carnitine.vrij & totaal & acylcarnitine panel in urine 100429-0 LRBA deficiency panel, Blood Déficience protéine LRBA panel [-] Sang ; - LRBA-deficiëntie panel in bloed 100430-8 Cells.LRBA+/Cells.CD3+CD14-CD45+, Blood LRBA+/100 cellules CD3+CD14-CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux Cellen.LRBA+/100 cellen.CD3+CD14-CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie 100431-6 T-cells LRBA MFI, Blood CD3+CD14-CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de flux Cellen.CD3+CD14-CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie 100432-4 Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+, Blood LRBA+/100 cellules CD3-CD14-CD19+CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux Cellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie 100433-2 B-cells LRBA MFI, Blood CD3-CD14-CD19+CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de flux Cellen.CD3-CD14-CD19+CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie 100434-0 Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Orthopoxvirus.non-variola, Specimen Orthopoxvirus non variola ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Orthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie 100435-7 Glial fibrillary acidic protein, Blood GFAP [Masse/Volume] Sérum ; Numérique ; Immunoanalyse Gliaal fibrillair acidisch proteïne [massa/volume] in serum d.m.v. immunoassay 100436-5 Ubiquitin carboxyl-terminal hydrolase-L1, Blood Ubiquitin carboxyl-terminal hydrolase-L1 [Masse/Volume] Sérum ; Numérique ; Immunoanalyse 100437-3 Norsufentanil, Urine Norsufentanil [Masse/Volume] Urine ; Numérique ; Confirmation Norsufentanil [massa/volume] in urine d.m.v. bevestiging 10043-8 S wave Amp L-V4 amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-V4 100438-1 Adolescent med OP Prog note 100439-9 Allergy+Immunology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. allergie+immunologie (document) 100440-7 Allergy OP Prog note 100441-5 Attend OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. behandelend arts (document) 100442-3 Audiology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. audiologie (document) 100443-1 Bariatric surg OP Prog note 100444-9 Bld Bnk+Trans Med OP Prog note 100445-6 BM Transplant OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. beenmergtransplantatie (document) 10044-6 S wave Amp L-V5 amplitud de la onda S.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-V5 100446-4 Breastfeeding OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. borstvoeding (document) 100447-2 Burn OP Prog note 100448-0 Cardiac surgery OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. cardiochirurgie (document) 100449-8 Cardio+Pulm dis OP Prog note 100450-6 Child+teen psych OP Prog note 100451-4 Chiropractic med OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. chiropractie (document) 100452-2 Electrophysiology OP Prog note 10045-3 S wave Amp L-V6 amplitud de la onda S.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S onda Amp L-V6 100453-0 Clinical genetics OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. klinische genetica (document) 100454-8 Clinical Neurophys OP Prog note 100455-5 Clin Path OP Prog note 100456-3 Col+rec surg OP Prog note 100457-1 Consultant OP Prog note 100458-9 OP COVID-19 Intub+Progress 100459-7 OP COVID-19 Progress note 100460-5 Dermatology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. dermatologie (document) 10046-1 S wave dur L-AVF duración de la onda S.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-AVF 100461-3 Develop-behav peds OP Prog note 100462-1 Dialy+Ther Apher OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. dialyse en therapeutische aferese (document) 100463-9 Eating disorders OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. eetstoornis (document) 100464-7 Endocrinology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. endocrinologie (document) 100465-4 Fam Med OP Prog note 100466-2 Gastroenterology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. gastro-enterologie (document) 100467-0 Geri med OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. geriatrie (document) 100468-8 Gyn Onc OP Prog note 100469-6 Gynecology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. gynaecologie (document) 100470-4 Navigator OP Prog note 100471-2 Heart failure OP Prog note 100472-0 HF+TC OP Prog note 100473-8 Hematology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie (document) 100474-6 HemOnc OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie + oncologie (document) 100475-3 Hepatology OP Prog note 100476-1 Immunology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. immunologie (document) 100477-9 Infectious disease OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. infectioloog (document) 100478-7 Internal Med OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. interne geneeskunde (document) 10047-9 S wave dur L-AVL duración de la onda S.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-AVL 100479-5 IC OP Prog note 100480-3 IR OP Prog note 100481-1 OP MCS+progress note 100482-9 MAiD OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. medische zorg bij sterven (document) 100483-7 Mental health OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. geestelijke gezondheidszorg (document) 100484-5 Multi-spec prog OP Prog note 100485-2 Neo peri med OP Prog note 100486-0 Nephrology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. nefrologie (document) 10048-7 S wave dur L-AVR duración de la onda S.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-AVR 100487-8 Neuro surgery OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurochirurgie (document) 100488-6 Neurology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurologie (document) 100489-4 Child neuro OP Prog note 100490-2 Nurse pract OP Prog note 100491-0 Nurse OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. verpleegkundige (document) 100492-8 Nutr+diet OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. voeding en diëtetiek (document) 100493-6 OBGYN OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie en gynaecologie (document) 100494-4 OB OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie (document) 10049-5 S wave dur L-I duración de la onda S.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Conduzca I:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-I 100495-1 OT OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. bezigheidstherapie (document) 100496-9 Oncology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. oncologie (document) 100497-7 Ophthalmol OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. oogheelkunde (document) 100498-5 Optometry OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. optometrie (document) 100499-3 OMS OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. oromaxillofaciale chirurgie (document) 100500-8 Orthopaedic surgery OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. orthopedische chirurgie (document) 100501-6 Orthotics prosthetics OP Prog note 100502-4 Otolaryngology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. KNO (document) 10050-3 S wave dur L-II duración de la onda S.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-II 100503-2 Pain medicine OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. pijnbestrijding (document) 100504-0 Palliative care OP Prog note 100505-7 Peds cardiology OP Prog note 100506-5 Peds dermatology OP Prog note 100507-3 Peds endocrinology OP Prog note 100508-1 Peds gastroenterology OP Prog note 100509-9 Peds hem-onc OP Prog note 100510-7 Peds infect disease OP Prog note 10051-1 S wave dur L-III duración de la onda S.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-III 100511-5 Peds otolaryngology OP Prog note 100512-3 Peds pulmonology OP Prog note 100513-1 Peds rheumatology OP Prog note 100514-9 Peds surgery OP Prog note 100515-6 Peds transpl hepato OP Prog note 100516-4 Peds urology OP Prog note 100517-2 Pharmacogenomics OP Prog note 100518-0 PM+R OP Prog note 100519-8 PT OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. fysiotherapie (document) 100520-6 Plastic surgery OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. plastische chirurgie (document) 100521-4 Podiatry OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. podologie (document) 100522-2 Psychiatric Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychiatrie (document) 100523-0 Psych OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychologie (document) 100524-8 Pulmonary disease OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. longaandoening (document) 100525-5 Radiation Onc OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiotherapie (document) 100526-3 Radiology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiologie (document) 100527-1 Rec therapy OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. recreationele therapie (document) 100528-9 REI OP Prog note 10052-9 S wave dur L-V1 duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-V1 100529-7 Research OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. wetenschappelijk onderzoek (document) 100530-5 Rheumatology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. reumatologie (document) 100531-3 Sleep med OP Prog note 100532-1 SW OP Prog note 100533-9 Solid Org Transplant OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatie van solide orgaan (document) 100534-7 Speech-lang path OP Prog note 100535-4 Spinal surgery OP Prog note 100536-2 Sports medicine OP Prog note 10053-7 S wave dur L-V2 duración de la onda S.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-V2 100537-0 Hand Surgery OP Prog note 100538-8 Telehealth+Outpatient Prog note 100539-6 Thromboemb OP Prog note 100540-4 Transpl surg OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatiechirurgie (document) 100541-2 Trauma OP Prog note 100542-0 Urology OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. urologie (document) 100543-8 Vasc Neuro OP Prog note 100544-6 Vascular surgery OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. vaatchirurgie (document) 10054-5 S wave dur L-V3 duración de la onda S.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-V3 100545-3 Wound care management OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. wondzorg (document) 100546-1 WOC OP Prog note 100547-9 Adolescent med Hosp Prog note 100548-7 Allergy+Immunology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. allergie+immunologie (document) 100549-5 Allergy Hosp Prog note 100550-3 Attend Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. behandelend arts (document) 100551-1 Audiology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. audiologie (document) 10055-2 S wave dur L-V4 duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-V4 100552-9 Bariatric surg Hosp Prog note 100553-7 Bld Bnk+Trans Med Hosp Prog note 100554-5 BM Transplant Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. beenmergtransplantatie (document) 100555-2 Breastfeeding Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. borstvoeding (document) 100556-0 Burn Hosp Prog note 100557-8 Cardiac surgery Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. cardiochirurgie (document) 100558-6 Cardio+Pulm dis Hosp Prog note 100559-4 Child+teen psych Hosp Prog note 10056-0 S wave dur L-V5 duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-V5 100560-2 Electrophysiology Hosp Prog note 100561-0 Clinical genetics Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. klinische genetica (document) 100562-8 Clinical Neurophys Hosp Prog note 100563-6 Clin Path Hosp Prog note 100564-4 Col+rec surg Hosp Prog note 100565-1 Consultant Hosp Prog note 100566-9 Dentistry Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. tandheelkunde (document) 100567-7 Dermatology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dermatologie (document) 100568-5 Develop-behav peds Hosp Prog note 100569-3 Dialy+Ther Apher Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dialyse en therapeutische aferese (document) 100570-1 Eating disorders Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. eetstoornis (document) 100571-9 Endocrinology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. endocrinologie (document) 100572-7 Fam Med Hosp Prog note 100573-5 Gastroenterology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gastro-enterologie (document) 100574-3 General medicine Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. algemene geneeskunde (document) 100575-0 Geri med Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geriatrie (document) 100576-8 Gyn Onc Hosp Prog note 100577-6 Gynecology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gynaecologie (document) 10057-8 S wave dur L-V6 duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S onda dur L-V6 100578-4 Navigator Hosp Prog note 100579-2 Heart failure Hosp Prog note 1005-8 Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood prueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: Prueba de antiglobulina indirecta Reactivo específico IgG: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: Test indirect à l'antiglobuline (TIA) IgG spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif Indirecte antiglobulinetest.IgG-specifiek reagent [aanwezigheid] in serum of plasma IAT IgG-Sp Reag SerPl Ql 100580-0 HF+TC Hosp Prog note 100581-8 Hematology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie (document) 100582-6 HemOnc Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie + oncologie (document) 100583-4 Hepatology Hosp Prog note 100584-2 Immunology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. immunologie (document) 100585-9 Infectious disease Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. infectioloog (document) 10058-6 S' wave Amp L-AVF amplitud de la onda S'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-AVF 100586-7 Internal Med Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. interne geneeskunde (document) 100587-5 IC Hosp Prog note 100588-3 IR Hosp Prog note 100589-1 Hosp MCS+progress note 100590-9 MAiD Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. medische zorg bij sterven (document) 100591-7 Mental health Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geestelijke gezondheidszorg (document) 100592-5 Multi-spec prog Hosp Prog note 100593-3 Neo peri med Hosp Prog note 10059-4 S' wave Amp L-AVL amplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-AVL 100594-1 Nephrology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. nefrologie (document) 100595-8 Neuro surgery Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurochirurgie (document) 100596-6 Neurology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurologie (document) 100597-4 Child neuro Hosp Prog note 100598-2 Nurse pract Hosp Prog note 100599-0 Nurse Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. verpleegkundige (document) 100600-6 Nutr+diet Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. voeding en diëtetiek (document) 100601-4 OBGYN Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie en gynaecologie (document) 10060-2 S' wave Amp L-AVR amplitud de la onda S'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conduzca AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-AVR 100602-2 OB Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie (document) 100603-0 OT Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. bezigheidstherapie (document) 100604-8 Oncology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oncologie (document) 100605-5 Ophthalmol Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oogheelkunde (document) 100606-3 OMS Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oromaxillofaciale chirurgie (document) 100607-1 Orthopaedic surgery Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. orthopedische chirurgie (document) 100608-9 Orthotics prosthetics Hosp Prog note 100609-7 Otolaryngology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. KNO (document) 10061-0 S' wave Amp L-I amplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-I 100610-5 Pain medicine Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. pijnbestrijding (document) 100611-3 Palliative care Hosp Prog note 100612-1 Pastoral Care Hosp Prog note 100613-9 Peds cardiology Hosp Prog note 100614-7 Peds dermatology Hosp Prog note 100615-4 Peds endocrinology Hosp Prog note 100616-2 Peds gastroenterology Hosp Prog note 100617-0 Peds hem-onc Hosp Prog note 100618-8 Peds infect disease Hosp Prog note 100619-6 Peds otolaryngology Hosp Prog note 100620-4 Peds pulmonology Hosp Prog note 100621-2 Peds rheumatology Hosp Prog note 100622-0 Peds surgery Hosp Prog note 100623-8 Peds transpl hepato Hosp Prog note 100624-6 Pharmacogenomics Hosp Prog note 100625-3 Pharmacology Hosp Prog note 100626-1 PM+R Hosp Prog note 100627-9 PT Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. fysiotherapie (document) 10062-8 S' wave Amp L-II amplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-II 100628-7 Plastic surgery Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. plastische chirurgie (document) 100629-5 Podiatry Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. podologie (document) 100630-3 Psych Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychologie (document) 100631-1 Radiation Onc Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiotherapie (document) 100632-9 Radiology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiologie (document) 100633-7 Rapid response team Hosp Prog note 100634-5 Rec therapy Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. recreationele therapie (document) 100635-2 REI Hosp Prog note 10063-6 S' wave Amp L-III amplitud de la onda S'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-III 100636-0 Research Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wetenschappelijk onderzoek (document) 100637-8 Rheumatology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. reumatologie (document) 100638-6 Sleep med Hosp Prog note 100639-4 SW Hosp Prog note 100640-2 Solid Org Transplant Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. transplantatie van solide orgaan (document) 100641-0 Speech-lang path Hosp Prog note 100642-8 Spinal surgery Hosp Prog note 100643-6 Hand Surgery Hosp Prog note 10064-4 S' wave Amp L-V1 amplitud de la onda S'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-V1 100644-4 Thromboemb Hosp Prog note 100645-1 Trauma Hosp Prog note 100646-9 Urology Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. urologie (document) 100647-7 Vasc Neuro Hosp Prog note 100648-5 Vascular surgery Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. vaatchirurgie (document) 100649-3 Wound care management Hosp Prog note Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wondzorg (document) 100650-1 WOC Hosp Prog note 10065-1 S' wave Amp L-V2 amplitud de la onda S'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-V2 100651-9 Hosp COVID-19 Intub+Progress 100652-7 Pure tone bone thresh Pnl 100653-5 Pure tone air thresh Pnl 100654-3 M2-PK (Pyruvatkinase) /Stuhl Pyruvatkinase M2 [Nachweis] in Stuhl Pyruvate kinase M2, Stool Pyruvate kinase M2 [Présence/Seuil] Selle ; Qualitatif Pyruvaatkinase M2 [aanwezigheid] in feces 100655-0 XR ST Lat 100656-8 Mat fetal med OP Prog note 100657-6 Mat fetal med Phone+Hosp Prog note 100658-4 Hosp COVID-19 Progress note 100659-2 Mat fetal med Hosp Prog note 1006-6 Direkter Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf Erythrozyten Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells prueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal: Prueba de antiglobulina directa Reactivo específico IgG: Eritrocitos : Punto temporal: Impresión / interpretación del estudio: Nominal: Test direct à l'antiglobuline (EDA) IgG spécifique [Interprétation] Érythrocytes ; Résultat nominal Directe antiglobulinetest.IgG specifiek reagens [interpretatie] in erytrocyten DAT IgG-Sp Reag RBC-Imp 100660-0 Mat fetal med Phone+OP Prog note 100661-8 Psychiatric OP Prog note Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychiatrie (document) 100662-6 Cortisol free and total panel, Blood Cortisol libre et total panel [-] Sérum/Plasma ; - Cortisol vrij & totaal panel in serum of plasma 100663-4 TPMT gene c.460G>A&c.719A>G, Blood TPMT gène c.460G>A et c.719A>G [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire TPMT-gen c.460G>A&c.719A>G [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100664-2 NUDT15 gene c.50_55dup&c.415C>T, Blood NUDT15 gène c.50_55dup et c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire NUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100665-9 NUDT15 gene c.415C>T, Blood NUDT15 gène c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire NUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100666-7 NUDT15 gene c.52G>A, Blood NUDT15 gène c.416G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire NUDT15-gen c.416G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100667-5 NUDT15 gene c.52G>A, Blood NUDT15 gène c.52G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire NUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100668-3 NUDT15 gene c.50_55dup, Blood NUDT15 gène c.50_55dup [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire NUDT15-gen c.50_55dup [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 10066-9 S' wave Amp L-V3 amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-V3 100669-1 NUDT15 gene c.50_55del, Blood NUDT15 gène c.50_55del [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire NUDT15-gen c.50_55del [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100670-9 Fetal RHD gene allele--fetus RHD gène allèle du fœtus [Identification] Plasma avec ADN libre circulant ; Résultat nominal RHD-allel^foetus [identificator] in plasma.celvrij DNA 100671-7 Aspergillus sp, Blood Aspergillus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible Aspergillus sp. DNA [aanwezigheid] in bloed d.m.v. probe-detectie 100672-5 Aspergillus fumigatus, Blood Aspergillus fumigatus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible Aspergillus fumigatus DNA [aanwezigheid] in bloed d.m.v. probe-detectie 100673-3 Aspergillus terreus, Blood Aspergillus terreus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible Aspergillus terreus DNA [aanwezigheid] in bloed d.m.v. probe-detectie 100674-1 BK virus, Blood BK virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible BK-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 100675-8 Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion Cytomegalovirus (CMV), Blood Cytomégalovirus ADN [Arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible Cytomegalovirus DNA [eenheid/volume] in bloed d.m.v. probe-detectie 100676-6 Cytomegalie-Virus DNA [log Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion Cytomegalovirus (CMV), Blood Cytomégalovirus ADN [Log arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible Cytomegalovirus DNA [logaritmische eenheid/volume] in bloed d.m.v. probe-detectie 10067-7 S' wave Amp L-V4 amplitud de la onda S'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-V4 100677-4 Epstein Barr virus (EBV), Blood Epstein barr virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible Epstein-Barr-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie 100678-2 Epstein Barr virus (EBV), Blood Epstein barr virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible Epstein-Barr-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 100679-0 Herpes virus (HHV) 6, Blood Herpes virus 6 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie 100680-8 Herpes virus (HHV) 6, Blood Herpes virus 6 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 100681-6 Herpes virus (HHV) 7, Blood Herpes virus 7 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie 100682-4 Herpes virus (HHV) 7, Blood Herpes virus 7 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 100683-2 Herpes virus (HHV) 8, Blood Herpes virus 8 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie 100684-0 Herpes virus (HHV) 8, Blood Herpes virus 8 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 10068-5 S' wave Amp L-V5 amplitud de la onda S'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-V5 100685-7 JC virus, Blood JC virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible JC-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie 100686-5 JC virus, Spinal fluid JC virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible JC-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie 100687-3 JC virus, Urine JC virus ADN [Log Nombre/Volume] Urine ; Numérique ; PCR amplification de cible JC-virus DNA [logaritmisch aantal/volume] in urine d.m.v. probe-detectie 100688-1 Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion Parvovirus B19, Blood Parvovirus B19 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible Parvovirus B19 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 100689-9 Toxoplasma gondii DNA [log #/Volumen] in Serum oder Plasma mittels Nukleinsäureamplifikation mit Sondendetektion Toxoplasma gondii, Blood Toxoplasma gondii ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible Toxoplasma gondii DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie 100690-7 Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion Toxoplasma gondii, Spinal fluid Toxoplasma gondii ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible Toxoplasma gondii DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie 100691-5 Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion Varicella zoster virus (VZV; Chickenpox), Blood Varicelle zona virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible Varicella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie 100692-3 Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion Varicella zoster virus (VZV; Chickenpox), Spinal fluid Varicelle zona virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible Varicella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie 10069-3 S' wave Amp L-V6 amplitud de la onda S'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG S' onda Amp L-V6 100693-1 Pneumocystis jirovecii, Respiratory system specimen Pneumocystis jiroveci ADN [Log Nombre/Volume] Échantillon du système respiratoire ; Numérique ; PCR amplification de cible Pneumocystis jiroveci DNA [logaritmisch aantal/volume] in respiratoir monster d.m.v. probe-detectie 100694-9 SMN1 gene silent carrier analysis, Blood or tissue specimen SMN1 gène analyse des porteurs silencieux [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaire Stille drager van SMN1-gen analyse [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100695-6 Genetic disease analysis overall carrier interpretation, Blood or tissue specimen Maladie génétique transmise interprétation globale [Interprétation] Sang/Tissu ; Résultat textuel ; Biologie moléculaire 100696-4 CTNS related multigene analysis, Body Fld+S/P Analyse multigénique en relation avec le CTNS [Identification] Liquide biologique+Sérum/Plasma ; Résultat nominal ; Biologie moléculaire CTNS-gerelateerde multigen-analyse [identificator] in lichaamsvloeistof en serum of plasma d.m.v. moleculair genetisch onderzoek 100697-2 IR OP Note 100698-0 SDOH screen report Doc 100699-8 Rifabutin/Ethambutol-Empfindlichkeit Rifabutin+Ethambutol [Empfindlichkeit] Susceptibility to Rifabutin+Ethambutol Rifabutine+éthambutol [Sensibilité] Isolat ; Alphanumérique Rifabutine + ethambutol [gevoeligheid] in isolaat 100700-4 Trichomonas vaginalis, Urethra Trichomonas vaginalis ADN [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible Trichomonas vaginalis DNA [aanwezigheid] in urethra d.m.v. probe-detectie 10070-1 S' wave dur L-AVF duración de la onda S'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-AVF 100701-2 Trichomonas vaginalis, Urethra Trichomonas vaginalis ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible Trichomonas vaginalis rRNA [aanwezigheid] in urethra d.m.v. probe-detectie 100702-0 Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit Sondendetektion Mycoplasma genitalium, Urethra Mycoplasma genitalium ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible Mycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie 100703-8 Mycoplasma genitalium rRNA [Nachweis] in Urin mittels Nukleinsäureamplifikation mit Sondendetektion Mycoplasma genitalium, Urine Mycoplasma genitalium ARNr [Présence/Seuil] Urine ; Qualitatif ; PCR amplification de cible Mycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie 100704-6 Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial vom Gebärmutterhals mittels Nukleinsäureamplifikation mit Sondendetektion Mycoplasma genitalium, Cervix Mycoplasma genitalium ARNr [Présence/Seuil] Col de l'utérus ; Qualitatif ; PCR amplification de cible Mycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie 100705-3 Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Mycoplasma genitalium, Anorectal Mycoplasma genitalium ARNr [Présence/Seuil] Anorectal ; Qualitatif ; PCR amplification de cible Mycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie 100706-1 Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Mycoplasma genitalium, Specimen Mycoplasma genitalium ARNr [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Mycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie 100707-9 Granulocytes, Peritoneal dialysis fluid Cellules polymorphonucléaires [Nombre/Volume] Liquide de dialyse péritonéale ; Numérique ; Comptage automate Granulocyten [aantal/volume] in periteonale dialysevloeistof d.m.v. geautomatiseerde telling 100708-7 Plasma cells/White Blood Cells, Synovial fluid Plasmocytes/100 leucocytes [Fraction de nombres] Liquide synovial ; Numérique Plasmacellen/leukocyten [getalsfractie] in synoviaal vocht 100709-5 Hepatocellular carcinoma risk Risque de cancer hépatocellulaire [Score] Patient ; Numérique ; GAAD Risico op hepatocellulair carcinoom [score] d.m.v. GAAD-score 100710-3 Chlamydia trachomatis and Neisseria gonorrhoeae panel, Throat Chlamydia trachomatis et Neisseria gonorrhoeae ARNr panel [-] Gorge ; - ; PCR amplification de cible Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel in keel d.m.v. probe-detectie 100711-1 Borrelia burgdorferi.VlsE1+pepC10 Antikörper [Einheiten/Volumen] in Serum mittels Immunoassay Borrelia burgdorferi.VlsE1+pepC10 antibody, Blood Borrelia burgdorferi VlsE1+pepC10 Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse Borrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay 100712-9 Brexpiprazol Brexpiprazole, Blood Brexpiprazole [Masse/Volume] Sérum/Plasma ; Numérique Brexpiprazol [massa/volume] in serum of plasma 100713-7 Cariprazin Cariprazine, Blood Cariprazine [Masse/Volume] Sérum/Plasma ; Numérique Cariprazine [massa/volume] in serum of plasma 100714-5 Guanfacin Guanfacine, Blood Guanfacine [Masse/Volume] Sérum/Plasma ; Numérique Guanfacine [massa/volume] in serum of plasma 100715-2 Prothipendyl Prothipendyl, Blood Prothipendyl [Masse/Volume] Sérum/Plasma ; Numérique Prothipendyl [massa/volume] in serum of plasma 100716-0 Prostate specific antigen, Dried blood spot Prostate spécifique antigène [Masse/Volume] Sang buvard ; Numérique Prostaatspecifiek Ag [massa/volume] in gedroogde bloedspot 100717-8 FCGR3A gene.p.Phe176Val, Blood or tissue specimen FCGR3A gène p.Phe176Val [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaire FCGR3A-gen.p.Phe176Val [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek 100718-6 Undersea+hyperbar D/C sum 10071-9 S' wave dur L-AVL duración de la onda S'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-AVL 100719-4 Surg Onc D/C sum 100720-2 REI D/C sum 100721-0 Comm hlth care D/C sum 100722-8 Integrative medicine D/C sum 100723-6 Sports medicine D/C sum 100724-4 Diabetology D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. diabetologie (document) 100725-1 Optometry D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. optometrie (document) 100726-9 Podiatry D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. podologie (document) 10072-7 S' wave dur L-AVR duración de la onda S'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. adelantar AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-AVR 100727-7 Chiropractic med D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. chiropractie (document) 100728-5 Cardiac surgery D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. cardiochirurgie (document) 100729-3 Breastfeeding D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. borstvoeding (document) 100730-1 Transpl surg D/C sum Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. transplantatiechirurgie (document) 100731-9 Urgent care D/C sum 100732-7 Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel, Blood Cholesterol Lp(a) et cholesterol LDL panel [-] Sérum ; - Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum 100733-5 LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), Blood Cholestérol LDL corrigé par cholestérol Lp(a) [Masse/Volume] Sérum ; Numérique ; Résultat calculé Cholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend 100734-3 traMADol and Metabolites Panel, Urine Tramadol et métabolites panel [-] Urine ; - ; Confirmation Tramadol & metabolieten panel in urine d.m.v. bevestiging 10073-5 S' wave dur L-I duración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-I 100735-0 Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cells Mannose-6-phosphate isomérase et phosphomannomutase 1 panel [-] Leucocytes ; - Mannose-6-fosfaatisomerase & fosfomannomutase 1 panel in leukocyten 100736-8 Acylcarnitine Analysis Post Mortem, Specimen Acylcarnitine post-mortem [Recherche] Milieux divers ; Document Acylcarnitine postmortale analyse [bevinding] (document) 100737-6 Alkaline phosphatase.macromolecular, Blood Phosphatase alcaline macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Alkalinefosfatase.macromoleculair [aanwezigheid] in serum of plasma 100738-4 Macromolecular alanine aminotransferase, Blood Alanine aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Alanine-aminotransferase.macromoleculair [aanwezigheid] in serum of plasma 100739-2 Macromolecular aspartate aminotransferase, Blood Aspartate aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Aspartaataminotransferase.macromoleculair [aanwezigheid] in serum of plasma 1007-4 Direkter Coombs Test polyspezifisch Direkter Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf Erythrozyten Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: Test direct à l'antiglobuline (EDA) polyvalente [Présence/Seuil] Érythrocytes ; Qualitatif Directe antiglobulinetest.polyspecifiek reagens [aanwezigheid] in erytrocyten DAT Poly-Sp Reag RBC Ql 100740-0 Amylase.macromolecular, Blood Amylase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Amylase.macromoleculair [aanwezigheid] in serum of plasma 100741-8 Gamma glutamyl transferase.macromolecular, Blood Gamma glutamyltransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Gamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma 100742-6 Lactate dehydrogenase.macromolecular, Blood Lactate déhydrogénase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Lactaatdehydrogenase.macromoleculair [aanwezigheid] in serum of plasma 10074-3 S' wave dur L-II duración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-II 100743-4 Lipase.macromolecular, Blood Lipase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif Lipase.macromoleculair [aanwezigheid] in serum of plasma 100744-2 Alpha-1-acid glycoprotein, Blood Orosomucoïde [Masse/Volume] Sérum/Plasma ; Numérique ; Électrophorèse Alfa-1-zure glycoproteïne [massa/volume] in serum of plasma d.m.v. elektroforese 100745-9 Chloride, Blood Chlorure [Moles/Volume] Sang mêlé veineux ; Numérique Chloride [mol/volume] in gemengd veneus bloed 100746-7 Glucose, Blood Glucose [Moles/Volume] Sang mêlé veineux ; Numérique Glucose [mol/volume] in gemengd veneus bloed 100747-5 Legionella serogroup panel, Specimen Legionella sérogroupe panel [-] Milieux divers ; - Legionella serogroep panel 100748-3 Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Legionella spp, Specimen Legionella spp [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Legionella spp. [aanwezigheid] d.m.v. probe-detectie 100749-1 Legionella pneumophila, Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Legionella pneumophila serogroup 1, Specimen Legionella pneumophila sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Legionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie 10075-0 S' wave dur L-III duración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-III 100750-9 Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Legionella pneumophila non-serogroup 1, Specimen Legionella pneumophila non sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Legionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie 100751-7 Galactose-alpha-1,3-galactose (Alpha-Gal) panel, Blood Galactose-alpha-1,3-galactose panel [-] Sérum/Plasma ; - Galactose-alfa-1,3-galactose panel in serum of plasma 100752-5 Exacerbating factors Reported 100753-3 Alleviating factors Reported 100754-1 Platelet disorders multigene analysis, Blood or tissue specimen Analyse multigénique des troubles plaquettaires [Recherche] Sang/Tissu ; Document ; Séquençage Trombocytopathie multigen-analyse [bevinding] in bloed of weefsel d.m.v. sequencing (document) 100755-8 Oligoclonal bands, Blood Protéines fractions oligoclonales [Nombre] Sérum/Plasma ; Numérique ; Isoélectrofocalisation Eiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren 100756-6 Oligoclonal bands, Spinal fluid Protéines fractions oligoclonales [Interprétation] Liquide céphalorachidien ; Résultat nominal ; Isoélectrofocalisation Eiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren 100757-4 Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluid Protéines fractions oligoclonales panel [-] Sérum+Liquide céphalorachidien ; - ; Isoélectrofocalisation Eiwitfracties.oligoklonale banden panel in serum en liquor cerebrospinalis d.m.v. iso-elektrisch focusseren 100758-2 Estimated lung age from clin data 100759-0 Inspiratory reserve vol spirometry 100760-8 XR Radius+Ulna-L 1V 100761-6 PALB2 gene targeted mutation analysis, Blood or tissue specimen PALB2 gène mutation cible trouvée [Recherche] Sang/Tissu ; Document ; Biologie moléculaire PALB2-gen doelgerichte mutatie-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) 100762-4 HBA2 gene.c.377T>C, Blood HBA2 gène c.377T>C [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire HBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek 100763-2 Mycobacterium sp comparative reaction interpretation, Skin Comparatieve reactie op Mycobacterium sp. Interpretatie [interpretatie] in huid (tekstueel) 100764-0 Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, Skin Mycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid 100765-7 Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spot Homocystéine et méthylmalonate et 2-méthylcitrate panel [-] Sang buvard ; - Homocysteïne & methylmalonaat & 2-methylcitraat panel in gedroogde bloedspot 100766-5 Center for Epidemiologic Studies Depression Scale panel [CES-D] 100767-3 Bothered by things that are not usually bothersome 10076-8 S' wave dur L-V1 duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-V1 100768-1 Poor appetite 100769-9 Unhappy even with help from my family or friends 100770-7 Feeling just as good as others 100771-5 Trouble focusing 100772-3 Feeling depressed 100773-1 Feeling everything is too much of an effort 100774-9 Feeling hopeful about the future 100775-6 Feeling life had been a failure 10077-6 S' wave dur L-V2 duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-V2 100776-4 Feeling fearful 100777-2 Restless sleep 100778-0 Feeling happy 100779-8 Quieter than usual 100780-6 Feeling lonely 100781-4 People were unfriendly 100782-2 Enjoying life 100783-0 Crying spells 10078-4 S' wave dur L-V3 duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-V3 100784-8 Feeling sad 100785-5 Feeling people dislike me 100786-3 Lack of energy 100787-1 Total Score CES-D 100788-9 Stemphylium botryosum IgG4 antibody Stemphylium botryosum Ac IgG4 [Masse/Volume] Sérum ; Numérique Stemphylium botryosum As.IgG4 [massa/volume] in serum 100789-7 Rhizopus nigricans IgG4 antibody Rhizopus nigricans Ac IgG4 [Masse/Volume] Sérum ; Numérique Rhizopus nigricans As.IgG4 [massa/volume] in serum 100790-5 Lepidoglyphus destructor IgG antibody Lepidoglyphus destructor Ac IgG [Masse/Volume] Sérum ; Numérique Lepidoglyphus destructor As.IgG [massa/volume] in serum 100791-3 Hamster epithelium IgG antibody Hamster (épithélium) Ac IgG [Masse/Volume] Sérum ; Numérique Hamsterepitheel As.IgG [massa/volume] in serum 10079-2 S' wave dur L-V4 duración de la onda S'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-V4 100792-1 Forsythia allergy test Forsythia Ac IgE [Arbitraire/Volume] Sérum ; Numérique Forsythia As.IgE [eenheid/volume] in serum 100793-9 Testosterone, Body fluid Testostérone [Masse/Volume] Liquide biologique ; Numérique Testosteron [massa/volume] in lichaamsvocht 100794-7 Follitropin (FSH; Follicle Stimulating Hormone), Body fluid Folliculostimuline [Arbitraire/Volume] Liquide biologique ; Numérique Follikelstimulerend hormoon [eenheid/volume] in lichaamsvocht 100795-4 S100 Calcium Binding Protein B, Body fluid Protéine S100B [Masse/Volume] Liquide biologique ; Numérique S100 calciumbindend eiwit B [massa/volume] in lichaamsvocht 100796-2 Thyroglobulin, Body fluid Thyroglobuline [Masse/Volume] Liquide biologique ; Numérique Thyreoglobuline [massa/volume] in lichaamsvocht 100797-0 Free testosterone 1st specimen after challenge, Blood Testostérone libre T01 après épreuve [Masse/Volume] Sérum ; Numérique Testosteron.vrij^1ste monster na XXX belasting [massa/volume] in serum 100798-8 Free testosterone 2nd specimen after challenge, Blood Testostérone libre T02 après épreuve [Masse/Volume] Sérum ; Numérique Testosteron.vrij^2de monster na XXX belasting [massa/volume] in serum 100799-6 21-Deoxycortisol 1st specimen after challenge, Blood 21-déoxycortisol T01 après épreuve [Masse/Volume] Sérum ; Numérique 21-deoxycortisol^1ste monster na XXX belasting [massa/volume] in serum 100-8 Cefoperazon [Empfindlichkeit] mittels Bestimmung der minimalen Hemmkonzentration (MHK) Susceptibility to Cefoperazone cefoperazona:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:concentración inhibitoria mínima Cefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC) Céfopérazone [Sensibilité] Isolat ; Alphanumérique ; CMI Cefoperazon [gevoeligheid] in isolaat d.m.v. minimaal inhiberende concentratie Cefoperazone Islt MIC 10080-0 S' wave dur L-V5 duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-V5 100800-2 21-Deoxycortisol 2nd specimen after challenge, Blood 21-déoxycortisol T02 après épreuve [Masse/Volume] Sérum ; Numérique 21-deoxycortisol^2de monster na XXX belasting [massa/volume] in serum 100801-0 21-Deoxycortisol 3rd specimen after challenge, Blood 21-déoxycortisol T03 après épreuve [Masse/Volume] Sérum ; Numérique 21-deoxycortisol^3de monster na XXX belasting [massa/volume] in serum 100802-8 21-Deoxycortisol 4th specimen after challenge, Blood 21-déoxycortisol T04 après épreuve [Masse/Volume] Sérum ; Numérique 21-deoxycortisol^4de monster na XXX belasting [massa/volume] in serum 100803-6 21-Deoxycortisol 5th specimen after challenge, Blood 21-déoxycortisol T05 après épreuve [Masse/Volume] Sérum ; Numérique 21-deoxycortisol^5de monster na XXX belasting [massa/volume] in serum 100804-4 Vasopressin 1st specimen after challenge, Blood Vasopressine T01 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^1ste monster na XXX belasting [mol/volume] in plasma 100805-1 Vasopressin 2nd specimen after challenge, Blood Vasopressine T02 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^2de monster na XXX belasting [mol/volume] in plasma 100806-9 Vasopressin 3rd specimen after challenge, Blood Vasopressine T03 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^3de monster na XXX belasting [mol/volume] in plasma 100807-7 Vasopressin 4th specimen after challenge, Blood Vasopressine T04 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^4de monster na XXX belasting [mol/volume] in plasma 100808-5 Vasopressin 5th specimen after challenge, Blood Vasopressine T05 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^5de monster na XXX belasting [mol/volume] in plasma 100809-3 Vasopressin 6th specimen after challenge, Blood Vasopressine T06 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^6de monster na XXX belasting [mol/volume] in plasma 100810-1 Vasopressin 7th specimen after challenge, Blood Vasopressine T07 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^7de monster na XXX belasting [mol/volume] in plasma 100811-9 Vasopressin 8th specimen after challenge, Blood Vasopressine T08 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^8ste monster na XXX belasting [mol/volume] in plasma 100812-7 Vasopressin 9th specimen after challenge, Blood Vasopressine T09 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^9de monster na XXX belasting [mol/volume] in plasma 100813-5 Vasopressin 10th specimen after challenge, Blood Vasopressine T10 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^10de monster na XXX belasting [mol/volume] in plasma 100814-3 Vasopressin 11th specimen after challenge, Blood Vasopressine T11 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^11de monster na XXX belasting [mol/volume] in plasma 100815-0 Vasopressin 12th specimen after challenge, Blood Vasopressine T12 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^12de monster na XXX belasting [mol/volume] in plasma 100816-8 Glucagon 6th specimen after challenge, Blood Glucagon T06 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique Glucagon^6de monster na XXX belasting [massa/volume] in serum of plasma 100817-6 Glucagon 7th specimen after challenge, Blood Glucagon T07 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique Glucagon^7de monster na XXX belasting [massa/volume] in serum of plasma 10081-8 S' wave dur L-V6 duración de la onda S'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG S' onda dur L-V6 100818-4 Renin 1st specimen after challenge, Blood Rénine T01 après épreuve [Masse/Volume] Plasma ; Numérique Renine^1ste monster na XXX belasting [massa/volume] in plasma 100819-2 Renin 2nd specimen after challenge, Blood Rénine T02 après épreuve [Masse/Volume] Plasma ; Numérique Renine^2de monster na XXX belasting [massa/volume] in plasma 1008-2 Indirekter Coombs Test polyspezifisch Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood prueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: Prueba de antiglobulina indirecta, reactivo específico de poli: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: Test indirect à l'antiglobuline (TIA) polyvalente [Présence/Seuil] Sérum/Plasma ; Qualitatif Indirecte antiglobulinetest.polyspecifiek reagent [aanwezigheid] in serum of plasma IAT Poly-Sp Reag SerPl Ql 100820-0 Renin 3rd specimen after challenge, Blood Rénine T03 après épreuve [Masse/Volume] Plasma ; Numérique Renine^3de monster na XXX belasting [massa/volume] in plasma 100821-8 POLST panel 100822-6 Cardiopulmonary resuscitation orders 100823-4 Initial portable medical treatment orders 100824-2 Additional portable medical orders or instructions 100825-9 Medically assisted nutrition orders 10082-6 ST I-Amp 6ms L-AVF amplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-AVF 100826-7 Portable medical order &or advance directive review 100827-5 Portable medical order discussion participants 100828-3 Portable medical order administrative information 100829-1 Renin 4th specimen after challenge, Blood Rénine T04 après épreuve [Masse/Volume] Plasma ; Numérique Renine^4de monster na XXX belasting [massa/volume] in plasma 100830-9 Free alpha subunit 1st specimen after challenge, Blood Sous unité alpha libre T01 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^1ste monster na XXX belasting [eenheid/volume] in serum of plasma 100831-7 Free alpha subunit 2nd specimen after challenge, Blood Sous unité alpha libre T02 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^2de monster na XXX belasting [eenheid/volume] in serum of plasma 100832-5 Free alpha subunit 3rd specimen after challenge, Blood Sous unité alpha libre T03 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma 100833-3 Free alpha subunit 4th specimen after challenge, Blood Sous unité alpha libre T04 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^4de monster na XXX belasting [eenheid/volume] in serum of plasma 10083-4 ST I-Amp 6ms L-AVL amplitud inicial del segmento ST, 6 mseg.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-AVL 100834-1 Free alpha subunit 5th specimen after challenge, Blood Sous unité alpha libre T05 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^5de monster na XXX belasting [eenheid/volume] in serum of plasma 100835-8 Free alpha subunit 6th specimen after challenge, Blood Sous unité alpha libre T06 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^6de monster na XXX belasting [eenheid/volume] in serum of plasma 100836-6 Free alpha subunit 7th specimen after challenge, Blood Sous unité alpha libre T07 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique Alfa-subeenheid.vrij^7de monster na XXX belasting [eenheid/volume] in serum of plasma 100837-4 Insulin-like growth factor-I 9th specimen after challenge, Blood Insulin-like growth factor 1 T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique Insulin-like growth factor-I^9de monster na XXX belasting [massa/volume] in serum of plasma 100838-2 Testosterone 9th specimen after challenge, Blood Testostérone T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique Testosteron^9de monster na XXX belasting [massa/volume] in serum of plasma 100839-0 Vitamin A/Retinol binding protein, Blood Vitamine A/retinol binding protein [Ratio] Sérum/Plasma ; Numérique Retinol/retinolbindend eiwit [verhouding] in serum of plasma 100840-8 IgE, Body fluid Immunoglobuline E [Arbitraire/Volume] Liquide biologique ; Numérique IgE [eenheid/volume] in lichaamsvocht 100841-6 Zinc finger protein of the cerebellum 4 antibody, Spinal fluid Zic4 anticorps [Présence/Seuil] Liquide céphalorachidien ; Qualitatif ; Blot en ligne Zinc finger proteïne of the cerebellum 4 As [aanwezigheid] in liquor cerebrospinalis d.m.v. lijnblot 10084-2 ST I-Amp 6ms L-AVR amplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-AVR 100842-4 Nonalcoholic steatohepatitis score, Blood Stéatohépatite non alcoolique - Score [Score] Sérum/Plasma ; Numérique ; Calculé FAST 100843-2 Liver fibrosis score, Blood Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile3+ 100844-0 Liver fibrosis score, Blood Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile4 100845-7 Neurofascin155 IgG4 antibody, Blood Neurofascine155 Ac IgG4 [Présence/Seuil] Sérum ; Qualitatif ; Cytométrie de flux Neurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie 100846-5 Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood Dengue virus 1+2+3+4 protéine non structurelle 1 (nsP1) [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay 100847-3 Gas and ammonia panel, Blood Gaz du sang et ammoniaque panel [-] Sang artériel ; - Gas en ammoniak panel in arterieel bloed 100848-1 Cell count and Differential panel, Amniotic fluid NFS - Hémogramme panel [-] Liquide amniotique ; - ; Comptage manuel Celtelling & differentieel panel in vruchtwater d.m.v. manuele telling 100849-9 White blood cell (WBC) count, Amniotic fluid Leucocytes [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel Leukocyten [aantal/volume] in vruchtwater d.m.v. manuele telling 100850-7 Neutrophils, Amniotic fluid Polynucléaires neutrophiles [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel Neutrofielen [aantal/volume] in vruchtwater d.m.v. manuele telling 100851-5 Other cells, Amniotic fluid Cellules autres [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel Overige cellen [aantal/volume] in vruchtwater d.m.v. manuele telling 100852-3 NM Bones Views for mets W Sr-89 IV 100853-1 NM Pericardial space 100854-9 Lymphocytes/cells, Blood Lymphocytes/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique ; Immunoanalyse Lymfocyten/cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay 100855-6 CD3 cells/cells, Blood CD3/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique Cellen.CD3/cellen [getalsfractie] in mononucleaire cellen in bloed 100856-4 CD3+CD4+ (T4 Helper) Cells/cells, Blood CD3+CD4+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique Cellen.CD3+CD4+/cellen [getalsfractie] in mononucleaire cellen in bloed 100857-2 CD3+CD8+ (T8 Suppressor) Cells/cells, Blood CD3+CD8+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique Cellen.CD3+CD8+/cellen [getalsfractie] in mononucleaire cellen in bloed 100858-0 Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood CD4+CD154+/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed 10085-9 ST I-Amp 6ms L-I amplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-I 100859-8 Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood CD4 exprimant l'interféron gamma/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed 100860-6 Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood CD4 exprimant le TNF alpha/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed 100861-4 Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood CD4+CD154+/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed 100862-2 Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood CD4 exprimant l'interféron gamma/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed 100863-0 Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood CD4 exprimant le TNF alpha/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed 100864-8 Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik Giardia lamblia bg gene genotype, Specimen Giardia lamblia gène bg [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire Giardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek 100865-5 Avian schistosomes, Specimen Aviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie 100866-3 Febrile antibody profile, Blood Profil d'anticorps fébriles [-] Sérum ; - 10086-7 ST I-Amp 6ms L-II amplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-II 100867-1 Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest Campylobacter jejuni+coli+lari+upsaliensis antigen, Stool Campylobacter jejuni+coli+lari+upsaliensis Ag [Présence/Seuil] Selle ; Qualitatif ; Immunoanalyse rapide Campylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest 100868-9 Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik Cryptosporidium sp 18S-LC2 genotype, Specimen Cryptosporidium ARNr 18S-LC2 [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire Cryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek 100869-7 Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels Molekulargenetik Cryptosporidium gp60 gene, Specimen Cryptosporidium gène gp60 [Type] Milieux divers ; Résultat nominal ; Biologie moléculaire Cryptosporidium gp60-gen [type] d.m.v. moleculair genetisch onderzoek 100870-5 Cryptosporidium 18S rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik Cryptosporidium 18S genotype, Specimen Cryptosporidium ARNr 18S [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire Cryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek 100871-3 Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik Giardia lamblia gdh gene genotype, Specimen Giardia lamblia gène gdh [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire Giardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek 100872-1 Bacteria producing polysaccharide from sucrose Bactérie productrice de polysaccharide du saccharose [Présence/Seuil] Isolat ; Qualitatif Uit sucrose polysacharideproducerende bacterie [aanwezigheid] in isolaat 100873-9 Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik Giardia lamblia tpi gene genotype, Specimen Giardia lamblia gène tpi [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire Giardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek 100874-7 Basidiobolus sp, Specimen Basidiobolus [Présence/Seuil] Milieux divers ; Qualitatif Basidiobolus sp. [aanwezigheid] 10087-5 ST I-Amp 6ms L-III amplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-III 100875-4 Fet Hrt Doc Ltd US 100876-2 Fet Hrt Doc US 100877-0 US Heart Transesophageal during surgery 100878-8 Endo US study Upr GI Tract Doc 100879-6 US Guided Brst-R Cryoablation 100880-4 US Guided Brst-L Cryoablation 100881-2 MR Guided Bone Cryoablation 100882-0 MR Peritoneum W contr percu 10088-3 ST I-Amp 6ms L-V1 amplitud inicial del segmento ST, 6 mseg.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG Deprecated ST initial amp 6 ms.lead 100883-8 MR Guided Kidney-L Bx 100884-6 MR Guided Kidney-R Bx 100885-3 Parapoxvirus , Specimen Parapoxvirus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Parapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie 100886-1 Orf virus, Specimen Orf virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Orfvirus DNA [aanwezigheid] d.m.v. probe-detectie 100887-9 Pseudocowpox virus, Specimen Pseudocowpox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible Pseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie 100888-7 Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Monkeypox virus clade II, Specimen Monkeypox virus clade II ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible 'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie 100889-5 Affenpocken-Virus Klade I DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion Monkeypox virus clade I, Specimen Monkeypox virus clade I ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible 'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie 100890-3 Poxvirus DNA panel Poxvirus ADN panel [-] Patient ; - Pokkenvirus DNA panel 10089-1 ST I-Amp 6ms L-V2 amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma ST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG ST I-Amp 6ms L-V2 100891-1 Orthopoxvirus IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay Orthopoxvirus IgG antibody, Blood Orthopoxvirus Ac IgG [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse Orthopoxvirus As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay 100892-9 Orthopoxvirus IgM-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay Orthopoxvirus IgM antibody, Blood Orthopoxvirus Ac IgM [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse Orthopoxvirus As.IgM [aanwezigheid] in serum of plasma d.m.v. immunoassay 100893-7 Orthopoxvirus IgG & IgM Ab panel, Blood Orthopoxvirus IgG et IgM Ac panel [-] Sérum/Plasma ; - Orthopoxvirus IgG & IgM As panel in serum of plasma 100894-5 Recommended screen freq 100895-2 Rickettsia conorii IgG and IgM antibodies, Blood Rickettsia conorii Ac IgG et IgM [Interprétation] Sérum ; Résultat nominal Rickettsia conorii As.IgG & IgM [interpretatie] in serum 100896-0 Vasopressin 13th specimen after challenge, Blood Vasopressine T13 après épreuve [Moles/Volume] Plasma ; Numérique Vasopressine^13de monster na XXX belasting [mol/volume] in plasma 100897-8 Staphylococcus aureus culture, Specimen Staphylococcus aureus [Présence/Seuil] Milieux divers ; Qualitatif ; Culture spécifique Staphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek 100898-6 Lipid panel, Blood Lipide panel [-] Sérum/Plasma ; - Lipiden panel in serum of plasma 100899-4 Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, Specimen Enterobacteriaceae phénotype de résistance aux bêta lactamases à spectre élargi [Identification] Milieux divers ; Résultat nominal ; Culture spécifique Enterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek

System

100881-2 http://loinc.org MR Guidance for cryoablation of Bone 100882-0 http://loinc.org MR Peritoneum W contrast percutaneous intraperitoneal 10088-3 http://loinc.org ST initial amplitude 6 ms in lead V1 100883-8 http://loinc.org MR Guidance for biopsy of Kidney - left 100884-6 http://loinc.org MR Guidance for biopsy of Kidney - right 100885-3 http://loinc.org Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection 100886-1 http://loinc.org Orf virus DNA [Presence] in Specimen by NAA with probe detection 100887-9 http://loinc.org Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection 100888-7 http://loinc.org Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection 100889-5 http://loinc.org Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection 100890-3 http://loinc.org Poxvirus DNA panel 10089-1 http://loinc.org ST initial amplitude 6 ms in lead V2 100891-1 http://loinc.org Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay 100892-9 http://loinc.org Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay 100893-7 http://loinc.org Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma 100894-5 http://loinc.org Recommended screening frequency Narrative 100895-2 http://loinc.org Rickettsia conorii IgG and IgM [Interpretation] in Serum 100896-0 http://loinc.org Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge 100897-8 http://loinc.org Staphylococcus aureus [Presence] in Specimen by Organism specific culture 100898-6 http://loinc.org Lipid panel - Serum or Plasma 100899-4 http://loinc.org Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture Additional Language Displays Code

Deutsch (Österreich) (German (Austria), de) Deutsch (Deutschland) (German (Germany), de) English (United States) (English (United States), en) Spanish (Argentina) (es) Spanish (es) French (France) (fr) Nederlands (Nederland) (Dutch (Netherlands), nl) Portuguese (Brazil) (pt) Ukrainian (uk) Display

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

Lvl

A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')

Display

The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code